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SUMMARY 
 
The extracellular matrix (ECM) is a dynamic environment that provides important cues 
for directing cell fate. Cells respond to and also actively remodel their ECM, and this 
dynamic remodeling of the ECM is essential for development, wound healing, and 
normal tissue homeostastis.  However, severe pathological conditions can arise when 
ECM remodeling becomes excessive or uncontrolled.  Dysregulation of the biochemical 
and biophysical properties of the ECM are observed in many types of disease including 
cancer and fibrotic pathologies such as pulmonary fibrosis and cardiovascular disease.  
These changes force cells into a non-homeostatic niche.  Specifically in the case of 
pulmonary fibrosis, biochemically the ECM is known to shift from a predominantly 
laminin/elastin matrix to a more provisional matrix comprised of fibrin and fibronectin 
(Fn).  In addition, the elasticity of fibrotic tissue has been shown to increase 
approximately nine-fold, drastically modifying the biophysical properties of the ECM. 
The stiffness of the underlying matrix has been shown to have many implications in 
directing cell fate.  For example, it has been shown that in response to increases in 
substrate stiffness, cells will adjust their internal stiffness to match that of their 
surroundings. As a consequence of this mechanical homeostasis between the cell and its 
ECM, cells in increasingly rigid, or stiff, environments display increased activation of 
contractile signals like Rho and Rho associated kinase (ROCK), which likely has 
multiple and diverse secondary effects, such as increases in forces applied by cells to the 
ECM.   As a consequence of stress application in the ECM, proteins comprising structural 
fibers (such as Fn) are known to display significant conformational changes (i.e. force-
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mediated partial unfolding), further contributing to biochemical alterations to the ECM.  
In the case of Fn, conformational changes can have great consequences on cell phenotype 
by altering integrin binding.  In this dissertation, it was hypothesized that such alterations 
in the ECM, mechanochemical alterations and stiffness, would lead to pathological 
cellular processes such as epithelial to mesenchymal transitions (EMT). 
 EMT, the phenotypic transdifferentiation of cells from epithelial to mesenchymal 
lineages, has been shown to contribute to the onset and progression of pulmonary 
fibrosis, as well as other types of fibrotic diseases and cancer metastasis.  While EMT is 
critical for wound healing and embryonic development, dysregulation of EMT leads to 
significant tissue and organ defects. EMT is a highly orchestrated process involving the 
integration of biochemical signals from ECM receptors (integrins) and growth factor 
receptors like transforming growth factor-  (TGF ) receptor and receptor tyrosine 
kinases.  TGF  has been identified as a potent inducer of EMT.  TGF  must be activated 
in order to bind to its receptors, which can occur through several mechanisms, one of 
which is through mechanical activation as a result of cell contractile forces.  Because it is 
a cell-mediated process, mechanical activation of TGF  is also influenced by both the 
biophysical and biochemical state of the ECM. Therefore, it was hypothesized that both 
increases in substrate stiffness or changes in integrin engagement would modulate cell 
contractility, leading to TGFβ activation and subsequently EMT. 
 This dissertation seeks to connect the biochemical and biophysical changes 
observed in the ECM during fibrosis to the pathological process of EMT.  Biochemically, 
the role of alterations in Fn conformation in the progression of EMT was investigated.  
Utilizing recombinant Fn fragments modeling different conformational states of the 
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molecule, integrin specific binding to the fragments and resulting downstream 
phenotypes were investigated.  Furthermore, the ability of the central cell binding domain 
of Fn to facilitate interactions with the classical laminin (Ln) receptor, integrin α3β1 were 
characterized.  Finally, the contribution of biophysical changes in the ECM to EMT was 
investigated, specifically analyzing the role of increased tissue stiffness in the onset and 
progression of EMT.  Utilizing poly-acrylamide gels of varying stiffness, EMT responses 
were characterized and the role of TGFβ activation/signaling in stiffness-mediated EMT 
was investigated. 
 The results presented here show that both the biochemical and biophysical state of 
the ECM contribute to the pathological progression of EMT.  Biochemically, Fn 
fragments displaying both the RGD and PHSRN binding sites facilitate cell binding 
through α5β1 and α3β1 integrins, and lead to maintenance of epithelial phenotype, while 
Fn fragments displaying only the RGD site facilitate cell binding through αv integrins 
and lead to enhanced activation of TGF  and EMT.  Furthermore, an in depth 
investigation into α3β1 binding to Fn fragments indicates that α3β1 integrin binding to Fn 
is dependent on both the presence and orientation of the PHSRN site.  Biophysically, 
increasingly rigid Fn substrates are sufficient to induce EMT and these responses are 
mediated by enhanced activation of TGF .  These results suggest that the cellular 
micromechanical environment is a significant contributor to the emergence of 








 Fibrosis, a potentially deadly pathology, is characterized by excessive deposition of 
extracellular matrix leading to stiffening of the surrounding tissue and ultimately loss of 
tissue structure and function. Many lung diseases such as pulmonary fibrosis, COPD, 
lung cancer, and emphysema, are extracellular matrix (ECM)-centric pathologies, 
meaning that the ECM, the structural scaffolding of the tissue, drives many of the 
pathological phenotypes contributing to the disease. (1-6)  
             Despite general scientific acceptance and significant published data illustrating 
the role of mechanical forces on cell phenotype, (7-12) there has been a considerable lack 
of attention to the role of ECM mechanics in the progression of lung pathologies.  During 
fibrosis, cells experience changes in their mechanical microenvironment at both the 
biophysical and biochemical level, such that their underlying ECM becomes stiffer, (13) 
while the biochemical composition of the ECM changes from a predominantly 
laminin/elastin matrix to exhibiting higher levels of provisional matrix proteins such as 
fibronectin (Fn).  (14) The precise mechanisms of the biophysical changes are not 
entirely clear, but could occur through changes in ECM composition through changed in 
gene expression, increased glycosylation, or increased cross linking of the matrix through 
tissue transglutaminases, lysyl oxidase, or other mechanisms. (15, 16)  In addition, shifts 
in cell populations to more contractile phenotypes can also contribute significantly to the 
mechanical-state of the ECM.  This phenomenon is highlighted by studies demonstrating 
that physiologically relevant fibroblast subpopulations associated with pulmonary fibrosis 
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generate Fn ECMs with markedly different mechanical signatures. (17)  Increased 
mechanical input from contractile cells can have great consequences on the state of the 
matrix by increasing the stiffness of the matrix as well as through altering the 
biochemical nature of fibrillar ECM proteins such as Fn.  Fn is highly sensitive to force-
mediated unfolding, and small force inputs can lead to distention within the cell-binding 
region, such that the RGD and PHSRN integrin binding sites are moved away from one 
other.  The relative positioning of the RGD and PHSRN site has been shown to influence 
α5β1 integrin binding, therefore, alterations in their positions can lead to differential 
integrin engagement, ultimately having great consequence on cell fate. (14, 18-20)  
 Recently, epithelial to mesenchymal transitions (EMT) have been implicated in the 
onset and progression of numerous fibrotic pathologies, including pulmonary fibrosis, 
renal fibrosis, and abhorrent wound healing/scar tissue formation. (21, 22)   EMT is 
characterized by a loss of cell-cell contacts, decreased expression of e-cadherin, and loss 
of polarity, accompanied by an increase in expression of mesenchymal markers including 
α-SMA, increased ECM production, and an increase in stress-fiber formation, cell 
contractility and mobility. (23, 24) EMT has been observed in vivo in bleoymycin-
induced pulmonary fibrosis in fibrotic regions of the lung. (25)  Furthermore, in vitro, 
alveolar epithelial type II (ATII) cells have been shown to undergo EMT in response to 
the underlying matrix; when cultured on Ln/collagen matrices epithelial cells maintain 
their phenotype, but when cultured on provisional Fn matrices the cells undergo EMT. 
(26)  Though the precise mechanisms leading to the onset of EMT are not well defined, it 
is clear that transforming growth factor beta (TGFβ) is a potent inducer of EMT.  (26-36)  
TGFβ must be activated in order to bind to its receptor(s), and can be activated through 
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several mechanisms including proteolytic cleavage, increases in pH, reactive oxygen 
species, and integrins.  (37-42)  Interestingly, TGF  can also be mechanically activated 
through cell contractile forces, which can be mediated through both biophysical events, 
as observed in fibroblasts in response to increases in substrate stiffness, (43) or through 
biochemical events, such as αv integrin engagement of Fn. (26)  Though it is clear that 
TGF  is a potent inducer of EMT and TGF  activation can be regulated by mechanical 
input, there is a little known about how force-induced changes in the ECM affect EMT. 
 The overall objective of this project was to characterize how the biophysical and 
biochemical nature of the ECM contribute to TGF  activation and subsequently EMT.  
The central hypothesis of this work was that both increases in substrate stiffness and 
changes in integrin engagement would modulate cell contractility, leading to TGF  
activation and subsequently EMT.  In this dissertation, the influence of substrate stiffness 
and integrin specific interactions, on ATII cell contractility, TGF  activation, and 
downstream regulation of EMT was investigated. Integrin-specific recombinant 
fragments of Fn type III repeats or polyacrylamide gels of varying stiffness were used to 
address the hypothesis through 3 specific aims: 1) Investigate modulation of EMT 
through 3/ 5 vs. v integrin binding to engineered integrin-specific Fn fragments; 2) 
Further characterize conformation specific binding of 3 1 integrin to Fn fragments; 3) 
Investigate the role of substrate stiffness-mediated increases in contractility in modulation 
of EMT. This work will provide insight into the pathological progression of pulmonary 
fibrosis and could uncover potential targets for therapeutics.   
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Specific Aim 1: Investigate modulation of EMT through 3/ 5 vs. v integrin 
binding to Fn fragments  
The hypothesis of this aim was that epithelial cells would engage FnIII9‟10 displaying 
both the RGD and PHSRN sites predominantly through 5 and 3 integrins, and FnIII10 
displaying only the RGD site predominantly through v integrins.  Because of 3 and 5 
integrins‟ known role in wound healing and αv integrins‟ known role in fibrotic 
progression, it was hypothesized that cells cultured on FnIII9‟10 would maintain an 
epithelial phenotype while cells cultured on FnIII10 would undergo EMT.  Integrin 
specific attachment to the Fn fragments was first determined through cell attachment 
assays and immunofluorescence staining for integrin subunits.  EMT was then analyzed 
through q-PCR and immunofluorescence staining for various epithelial and mesenchymal 
markers.  Furthermore, proper wound healing was assessed through an in vitro wound 
healing assay.  The role of TGF  signaling was analyzed through q-PCR analysis of Pai-
1 mRNA expression. 
Specific Aim 2: Establish the conformation specific binding of 3 1 integrin to FN 
fragments. 
Based on initial results from cell attachment assays and immunofluorescence staining on 
Fn fragments indicating that epithelial cells engage FnIII9‟10 via 3 1 integrin but not 
FnIII10, it was hypothesized that 3 1 integrin binds to the central cell binding domain 
of Fn in a PHSRN-dependent manner. To explore this hypothesis, a variety of 
recombinant Fn III9‟10 variants displaying an ARG to ALA mutation in the synergy site 
(FnIII9
RA10), and a 2 GLY insertion (FnIII9
2G
10) or a 4 GLY insertion (FNIII9
4G
10) 
between FnIII9 and FnIII10 were created.  Surface plasmon resonance (SPR) was used to 
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determine binding kinetics of integrin 3 1 binding to the Fn fragments.  In addition, 
cells spreading responses on Fn fragments were investigated. 
Specific Aim 3: Investigate the role of substrate stiffness in modulating EMT 
The working hypothesis of this aim was that cells on increasingly stiffness substrates will 
become more contractile, leading to increased TGF  activation/signaling, and 
subsequently increased EMT.  Stiffness mediated EMT was investigated by culturing 
alveolar epithelial cells on polyacrylamide gels of varying stiffness with Fn cross-linked 
to the surface or on Fn or Ln-coated glass as controls.  EMT was investigated through 
western blot and immunofluorescence analysis of various epithelial and mesenchymal 
markers.  Cell contractility was investigated through analysis of stress-fiber formation 
and quantification of single cell stiffness through AFM probing.  Based on the hypothesis 
that increases in cell contractility contribute to stiffness-mediated EMT, EMT was 
characterized on substrates of varying stiffness in the presence of the contractility 
inhibitor, Y-27632.  The role of TGF  activation/signaling in response to increasingly 
rigid substrates in the presence or absence of Y-27632 was investigated through qPCR 
for the TGF  responsive gene, Pai-1.  The role of TGF  signaling was further analyzed 
by analysis of EMT events and Pai-1 signaling in the presence of active TGF  on soft 
substrates and in the presence of TGF  neutralizing antibodies on rigid substrates. 
    This body of work focuses on a highly significant unknown in the field of 
pulmonary repair, remodeling, and pathogenesis by investigating the role of the integrin 
specific binding and stiffness of the ECM in modulating EMT.  While traditional 
approaches have sought to understand the role of full length Fn on rigid surfaces on 
epithelial cells, this study focuses on 1) the role of mechanically unstable, integrin 
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binding regions of Fn that likely display altered conformations over time and their role in 
the progression of interstitial pulmonary disorders through the regulation of cell-integrin 
engagement and 2) the role of increases in tissue stiffness, over the range of tissue 
stiffness observed in pulmonary fibrosis in vivo, in modulating EMT. Understanding 
these processes will provide insight into how mechanical forces, ECM remodeling, and 
mechanical regulation of TGF  signaling contribute to the pathological progression of 
pulmonary fibrosis and could uncover potential targets for therapeutics.  Furthermore, 
most of what is known about EMT has been performed on rigid substrates.  This work is 
significant, because it illustrates the integration of both biochemical and biophysical 
signals from the ECM in TGF  activation and the pathological progression of EMT.  
Current therapeutics for fibrotic diseases such as TGF  antibodies focus on treating the 
cells, but this work suggests that the state of the matrix should also be considered in 
development of effective therapeutics. 
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CHAPTER 2 
BACKGROUND 
Fibrosis and EMT 
 Fibrotic pathologies are characterized by excessive ECM production, 
interstitial scar tissue formation, and an increase in tissue stiffness.  During the course of 
idiopathic pulmonary fibrosis (IPF), the experimental disease model utilized for this 
work, functional lung tissue of the alveoli is replaced with collagen-rich ECM, leading to 
rapid and severe decreases in lung compliance and irreversible loss of lung function. (1, 
2)  IPF is a currently untreatable and ultimately fatal condition with 3 and 5 year 
mortality rates of 50% and 80%, respectively. (3)  In addition to formation of scar tissue, 
another hallmark of IPF and other fibrotic conditions is the influx of extremely 
contractile myofibroblasts.  The influx of myofibroblasts further perpetuates the disease 
through persistent matrix production and contraction, contributing to increased cytokine 
activation.  Lack of effective treatment options for this disease, and many other fibrotic 
diseases is largely due to lack of understanding of the exact mechanisms initiating 
fibrosis, however recent studies implicate alveolar epithelial to mesenchymal transitions 
(EMT) in the onset and progression of fibrosis. (4-9)  EMT has been theorized to increase 
the number of ECM secreting mesenchymal cells, and cell tracking studies have 
demonstrated that a considerable number of myofibroblasts arise from EMT. (6, 10)  
EMT is the de-differentiation of an epithelial cell into a mesenchymal cell, and is 
defined through the loss of apical-basolateral polarity, loss of tight cell junctions, and a 
marked down-regulation of E-cadherin.  These changes are accompanied by concomitant 
up-regulation of α-smooth muscle actin (α-SMA), increased stress fiber formation and 
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alignment, increased migration through filopodia and lamellopodia formation, and an 
increased synthesis of ECM.  EMT is important during normal cellular processes in 
wound healing, embryogenesis, and development, contributing to wound-closure, 
blastocyst implantation, gastrulation, generation of the neural crest, and palate closure. 
(11-13)   Highlighting the importance of EMT in wound healing of the skin, 
keratinocytes at the wound edge undergo partial EMT, acquiring an intermediate 
phenotype characterized by loose cell-cell contacts and migration that allow for wound 
closure. (14)  Though EMT is clearly an important cellular transition, if not tightly 
regulated, EMT can lead to abhorrent wound healing and scar tissue formation in mature 
tissues, contributing to pathological conditions such as keloids, pulmonary fibrosis, and 
renal fibrosis, or through a similar process of endothelial to mesenchymal transition, an 
contribute to cardiac fibrosis.  Furthermore, EMT contributes to cancer metastisis, as 
epithelial cells take on a migratory mesenchymal phenotype that allows them to invade 
secondary epithelia. 
EMT has been shown to occur in response to several factors such as growth 
factors including transforming growth factor beta (TGFβ), tumor necrosis factor alpha 
(TNFα), epidermal growth factor (EGF), and reactive oxygen species, as well as in 
response to extracellular matrix proteins including fibronectin (Fn). (15-19)  The role of 
TGFβ is most well defined of all these factors, and is known to be a potent inducer of 
EMT.  TGFβ signaling is quite complex and can activate a number of different pathways, 
including SMAD-dependent and independent pathways. (20-22)  SMAD dependent 
signaling can lead to Snail1 activation, which plays a role in EMT by down regulating E-
cadherin expression and up regulating a number of mesenchymal genes including 
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vimentin and α-SMA. (23-25)  Though many advances have been made in understanding 
factors contributing to EMT, precise events leading to the initiation of EMT remain 
unclear.  This dissertation focuses on the role of the extracellular matrix 
microenvironment in the onset of EMT of ATII cells.   
Alveolar Type II Epithelial Cells 
ATII cells in pulmonary homeostasis/repair: 
 Understanding normal pulmonary homeostasis and repair can provide insight into 
anomalous cellular interactions that lead to pathological EMT in pulmonary fibrosis.  
Pulmonary remodeling and repair follows roughly the same process as healing of any 
epithelial barrier, namely the proliferation, migration and differentiation of epithelial cells 
in response to provisional and intermediate ECMs.  In pulmonary tissue, disruption of 
underlying vasculature results in the initiation of the clotting cascade and the creation of a 
fibrin-rich provisional ECM with interspersed cross-linked Fn, which is ultimately 
degraded by invading interstitial mesenchymal fibroblasts and replaced with an 
intermediate Fn-rich ECM. (26)  Alveolar epithelial cells interact with the provisional 
and intermediate matrix through cell surface ECM-binding receptors known as integrins.  
The intermediate Fn-rich ECM provides important biochemical cues directing apical 
epithelial cell proliferation and differentiation as well as other functions (27) and acts as 
the initial template for the more permanent collagen-laminin-elastin matrix of the lung. 
(28) 
The ATII cell is the primary cell type associated with proper maintenance of pulmonary 
tissue, i.e. alveolar homeostasis and repair. (29) Adult pulmonary tissue is composed of 
over 40 different cell types and possesses over 300 million alveoli, the primary functional 
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structure of lung. Two primary epithelial cells populate the alveolus, Type I and II 
alveolar epithelial cells (ATI and ATII).  ATI cells, separated from capillaries by only a 
thin basement membrane, are the primary gas-exchange cells and comprise 90% of the 
alveolar surface yet only 10% of the epithelial cell number. (30) ATII cells are pseudo-
cuboidal, multifunctional cells that are considered the “protector of the alveolus” due to 
their central role in defense and repair.  ATII cells act as the primary surfactant-secreting 
cell, precursors to ATI cells, and in many instances as non-professional antigen-
presenting cells. (31) ATII cells also contribute significantly to the fluid balance across 
the epithelial barrier through sodium transport functions. (32) These various functions 
underscore the vital importance of these cells in maintaining pulmonary function. During 
normal repair, ATII cells are thought to proliferate, migrate onto a provisional matrix and 
differentiate into ATI cells.   
 Despite their obvious beneficial effects, recent evidence suggests that repeated 
injury of ATII cells may be the primary cause of pulmonary fibrotic disorders. (31, 33-
35) Lung biopsies of patients with pulmonary fibrosis show fragmented DNA (indicative 
of apoptosis) in alveolar epithelium (36) and apoptotic alveolar epithelial cells are 
observed adjacent to foci of myofibroblasts. (24, 25, 37) As discussed, an important 
emerging hypothesis is that ATII cells may serve as the source of EMT. (4, 6, 38)  It has 
been demonstrated that ATII cell EMT can be potently induced by transforming growth 
factor beta-1 (TGF ) in vitro and in vivo. (4, 18, 38-40)  The extracellular matrix has also 
been shown to play a critical role in alveolar EMT. (6)  Primary ATII cells cultured on 
provisional matrices (fibrin-fibronectin) undergo EMT via v 6 integrin-dependent 
activation of endogenous TGF , while cells cultured on laminin/collagen mixtures do not 
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activate TGF . (6)  This response is integrin-dependent, such that integrins are required 
not only in the binding to matrix proteins, but also for activation of TGF , therefore ATII 
integrin binding/signaling plays a pivotal role in modulating EMT, though this has not 
been thoroughly investigated.   
ATII cell integrins:  expression and functions:  
 ATII cells have been shown to express a wide range of integrins.  At least 7 integrin 
pairs are expressed in healthy adult ATII cells including 2 1, 3 1, 6 4, 9 1, v 5, 
v 6, and v 8.  Though not present in healthy airway epithelium, 5 1 integrin 
expression is rapidly induced in response to injury, and is therefore important for wound 
healing responses. (41)  These integrins are known to have various roles in epithelial 
homeostasis, repair, and possibly pathologic responses, including maintaining epithelial 
integrity ( 6 4 and 3 1 (41)), regulating wound-repair processes, (27) and activation of 
TGF  ( v 6 and v 8 (42, 43)). 
 Recent studies have illustrated the importance of 3 1 integrin in maintaining 
epithelial integrity.  The classical ligand for 3 1 is laminin (41, 44) but is also known to 
bind collagen and fibronectin.  (45-47)  Integrin 3 is important in alveolar epithelial 
monolayer formation. (48)  ATII 3 mRNA has been shown to decrease in response to 
TGF , (49) implying a role for 3 1 in regulating EMT in the lung.  Downregulation of 
3 integrin has been noted in response to EMT driven by the transcription factor Slug. 
(49, 50).  In addition, a decrease in expression of 3 1 integrin is commonly seen in 
cancer related EMT and is associated with a more malignant phenotype and poor patient 
prognosis. (51)  Antibody inhibition experiments with airway epithelial cells shows a 
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significant decrease in wound-repair in the presence of either anti- 1, anti- 3, anti- 5, or 
anti-fibronectin antibodies, suggesting that 3 may also play a role in the wound repair 
process. (27)  3 1 null keratinocytes display higher concentrations of actin-associated 
proteins such as vinculin, tailin, and -actin at focal contact sites compared to wild type 
cells, indicating that this integrin is important in the regulation of focal adhesion and 
stress fiber formation. (52)  3 1 causes a suppression of cytokine responses by 
epithelial cells indicating an important role for this integrin during inflammation or 
wound healing. (53)  Interestingly, it has also been suggested that 3 1 may act as a 
transdominant inhibitor of other integrins; 3-null keratinocytes show an increase in Fn 
and CollIV receptors. (52) This transdominant effect of 3 has also been shown to play a 
pivotal role in anti-tumorigenic activities. (54)  This data suggests a potential role for 3 
integrin in the prevention/inhibition of EMT through the regulation of other integrins 
associated with pathological states (such as V). Taken together, this evidence suggests a 
role for 3 1 signaling in preventing alveolar EMT by maintenance of monolayer 
formation, inhibition of focal adhesion and stress fiber formation, suppression of cytokine 
responses, and transdominant inhibition of other integrins.   
 The provisional matrix protein Fn has the capacity to bind many of the integrins 
expressed by ATII cells, including v 3, v 6, 3 1, and 5 1 (during injury).  (27, 45, 
47, 55)  Integrin 3 1 binding to Fn has been shown to occur in an RGD dependent 
fashion, but interestingly, 3 1 binding to Ln and Col is not through RGD sites. (45)  
Integrin 3 1 binding to Fn can be affected by the presence of 5 1 integrin such that 
3 1 binding is low in cells expressing 3 1 and 5 1 at comparable levels, but 3 1 
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binding to Fn is greatly enhanced in H69 cells that highly express 3 1 compared to 
other integrins.  Because ATII cells only express 5 1 integrin in response to injury, (27) 
it is likely that integrin 3 1 binds Fn with great affinity in this cell type under normal 
conditions.  Though 5 1 appears to be the main Fn receptor during alveolar wound 
repair, integrin blocking experiments with airway epithelial cells showed that in addition 
to 5, 1, and Fn blocking antibodies that 3 blocking antibodies also resulted in a 
significant decrease in wound repair. (27) This suggests that initial binding of 3 1 to Fn 
may modulate wound repair.  The competing effects of ATII cell engagement of various 
integrins likely plays a significant role in the determination of cell phenotype leading to 
normal alveolar repair or pathological EMT events.  This dissertation specifically 
addresses the role of Fn in the progression of ATII cell EMT versus maintenance of 
epithelial phenotype.  A central hypothesis of this dissertation was that mechanical forces 
activate integrin “switches”, based on domain unfolding, within Fn that regulate integrin 
specificity and thus activation of different cell signaling cascades.    
Fibronectin 
 Although Fn has a wide variety of functions, it is the capacity to bind multiple 
integrins and initiate specific intracellular signals that give this protein such importance 
in directing cell and tissue state.  Biochemically, Fn is a soluble dimeric glycoprotein 
composed of two nearly identical 230-270 kDa monomers linked covalently near their C- 
termini by a pair of disulfide bonds. (reviewed by (47, 56))  Each monomeric subunit 
consists of three types of repeating modules, type I, II and III. These modules comprise 
functional domains that mediate interactions with other ECM components, cell surface 
receptors, and Fn itself. (47)  Whereas type I and II repeats are structurally stabilized with 
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two intrachain disulfide bonds in each repeat, type III repeats have no disulfide bonds and 
therefore are highly sensitive to force-mediated unfolding.  Fn is encoded by a single 
gene yet as many as 20 variants of human Fn are produced each having slight differences 
in the composition and number of type I, II, and III repeats.  All isoforms are capable of 
being incorporated into a fibrillar polymer.  
 As mentioned, Fn‟s role in directing cell and tissue homeostasis and repair is 
through the binding and activation of the cell surface ECM receptors known as integrins.  
The most studied integrin recognition sequence, RGD (Arg-Gly-Asp), is located on the 
10th type III repeat. The recognition of this simple tripeptide sequence can be quite 
complex and greatly depends on flanking residues, its three dimensional presentation, and 
individual features of the integrin-binding pockets. For example, RGD in concert with a 
second recognition sequence (PHSRN), the so-called “synergy” site, in the adjacent 9th 
type III repeat is known to promote the specific interaction of 5 1 integrin binding to 
Fn through interactions with the 5 subunit. (57, 58) Importantly, the spatial orientation, 
and thus synergistic activity, of the RGD and synergy cell adhesion peptides is highly 
sensitive to mechanical forces generated by resident cells. 
Force-mediated unfolding of Fn:   
 Fn is extremely sensitive to mechanical forces, a fact that is exemplified by its own 
polymerization into fibrillar form. (59, 60)  Soluble Fn is compact and has very few sites 
for interaction with other proteins.  Thus Fn must undergo significant conformation 
changes to allow self-binding to cryptic sites near the N-terminus during polymerization 





repeats).  These conformation changes are naturally driven by the input of cellular energy 
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in the form of cell contractile forces. The type-III repeats that comprise the cell-binding 
domain within Fn are particularly sensitive to mechanical forces since these individual 
domains are stabilized only by van der Waals forces and hydrogen bonding between 
amino acid side-chains of opposing beta sheets.  While it has long been observed that the 
alveolar wall experiences levels of approximately 25% cyclic strain due to inhalation, 
(61) it is improbable that this level of strain significantly contributes to the tension 
observed in native Fn ECMs within the lung.  Recent studies on cell-mediated Fn 
molecular unfolding provide evidence to this fact. Specifically, loss of in vitro cellular 
contraction through inhibition of actin polymerization results in significant relaxation of 
Fn into a more compact conformation (62) while inhibition of cell contractility in excised 
(ex vivo) frog embryo tissue results in a completely collapsed Fn conformation. (63)  
Furthermore, extraction of cells from fibroblast-derived Fn ECMs and quantification of 
the Fn molecular collapse indicates that cells strain Fn fibers (and unfold type-III repeats) 
between 200 and 700%; (64) values greater than an order of magnitude more than could 
be accounted for by inhalation-mediated strain.  Strain associated with inhalation clearly 
has significant effects on epithelial cell behavior, however these recent studies emphasize 
that tension in the underlying ECM resulting in Fn molecular unfolding originates from 
resident mesenchymal cells (e.g. pulmonary interstitial fibroblasts) rather than bulk 
organ-level mechanics.  
Fn conformational changes direct changes in integrin specificity:   
 The best-defined model of Fn unfolding at the secondary level having a significant 
impact on integrin engagement and subsequent cell fate is domain unfolding of the RGD-
containing 10
th
 type III repeat.  Due to the elasticity of type III repeats, the 9th and 10th 
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type III repeats together present multiple conformations that direct integrin specificity to 
this region.  The synergy site, located on the 9th type III repeat is located approximately 
32Å from the RGD-loop on the 10th type III repeat in solution.  In this conformation the 
two motifs act synergistically to bind 5 1 integrin. (43) Under small forces (<100 pN) 
the 10
th
 type-III repeat, prior to complete unfolding, assumes an intermediate state 
characterized by the RGD loop translocating away from the 9
th
 type-III repeat. In this 
state, the synergy–RGD distance is increased from 32Å to approximately 55Å, a distance 
too large for both sites to co-bind the same receptor.  This is further evidenced by 
experiments that demonstrate increasing the length of the linker chain between the two 
repeats by insertion mutation reduces 5 1 binding. (65) These data suggest that 5 1 
binding attributed to the synergy site can be turned off mechanically by stretching these 
domains into this intermediate state or beyond.  The effect of force-mediated unfolding of 
Fn on integrin engagement and activity levels may be further explained by studies 




) type III repeat, can 
modulate integrin accessibility of the RGD motif. A stabilization of the 9
th
 repeat via a 
Leu to Pro point mutation at amino acid 1408 (66) or stabilization of the hydrogen 
bonding within the 10
th
 type-III repeat (67) increases affinity for 5 1 over V 3.   
 Importantly, the exact composition of Fn isoforms, with respect to its type-III 
repeats, will play a significant role in determining the overall stability of the molecule 
since the stability of type-III repeats are critically dependent on neighboring type-III 
repeats. (68)  This fact has particular relevance to pulmonary fibrosis.  Fn-EDA, which 
has been consistently linked to fibrosis and is expressed at high levels in pulmonary 
fibrosis, (69) contains an extra type-III repeat, the EDA domain (inserted following the 
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11
th
 type-III repeat) which is extraordinarily unstable.  The NMR spectra of the EDA 
domain demonstrates that it is mostly in an unfolded state at 37 C and can be completely 
unfolded upon the removal of four amino acids at its N-terminus.  (70)  This data suggest 
the EDA type-III repeat is a “hyper” mechano-sensitive type-III repeat of Fn that is 
predicted to cause local conformational alterations through the potential destabilization of 
the remaining type-III repeats.  This example is particularly interesting, since the 




 type-III repeats 
resulting in preferential engagement of certain integrins over others.   
 Integrin specificity is clearly linked to cell fate determination and differentiation 
and proliferation processes.  For example, the 1 integrin subunit enhances the 
progression of differentiation of precursor cells, (71, 72) while v integrins, like v 3, 
correlate with increased cell adhesion, (73) enhanced cell proliferation, and decreased 
differentiation. (74)  Fn has been shown to cause a switch between stimulation of 
proliferation and differentiation of mouse C2C12 myoblasts to myotubes (75) and 
MC3T3-E1 osteoblast-like cells (72) by a yet to be identified structural change that 
results in an increase of the 5 1-to- v 3 binding ratio.   
 From these published studies it is clear that the application of mechanical forces 
to Fn ECM, resulting in conformation changes, likely has a significant impact on the 
integrin specificity with which cells engage Fn, and in turn modulate cell behavior 
through intracellular signaling events.  The first aim of this project applies these 
fundamental principles of Fn dynamics to the process of integrin engagement and 
epithelial cell fate during pulmonary remodeling and progression of fibrosis by 
determining the effects of altering the stretched state of Fn ECM on ATII cell integrin 
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engagement and phenotypic alteration.  The second aim of this project further 
characterizes the dependence of epithelial cell integrin interactions with a dynamic Fn 
molecule by investigating the role of the Fn synergy site in integrin α3β1 binding.  
TGF  Activation and Signaling 
Cell-mediated mechanical forces play an integral role in Fn unfolding and conformation 
changes that alter integrin specificity.  Recent studies have shown that cell contractility 
and regulation of integrin expression also play a critical role in TGF -1 activation, 
which, as previously mentioned, is a critical mediator of EMT.  TGF  regulates a wide-
array of cellular processes associated with normal homeostasis and repair, including 
proliferation, differentiation, motility, apoptosis, and tumor suppression.  (76, 77)  
Because TGFβ is a potent inducer of EMT and many other cellular events, its 
presentation must be tightly controlled.  TGFβ exists in an inactive form, and must be 
activated in order to bind to its receptor.   In its inactive form, TGFβ forms a complex 
with the latency-associated peptide (LAP), and this non-covalent association is termed 
the small latent complex.  This small latent complex can go on to form a large latent 
complex by binding the latent TGFβ binding protein, which allows for immobilization of 
the inactive TGFβ the ECM.  (78-80)  The latent complex of TGFβ can be activated in 
the lung through two distinct mechanosensitive events. First, activation can occur through 
binding of the latency-associated protein complex to integrins v 6 or v 8 via RGD 
sequences.  (42, 81, 82) Application of cell contractile forces to the integrin-LAP 
complex results in a prying of the LAP complex away from TGF  and either releasing 
the active growth factor in a soluble form (when bound through v 8 integrin) or 
exposing it temporally to neighboring cells (when bound through v 6 integrin). (83) 
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Second, activation has been proposed to occur through a similar releasing process of 
TGF  bound within the ECM via the large latent complex. (84)  Both processes of TGF  
activation are directly related to integrin expression and cell contractility.  As mentioned 
before, engagement of 3 1 integrin has been shown to regulate the expression and 
engagement of other integrins (such as v) and regulate cell contractility.  Recent reports 
have linked 3 1 integrin to TGF -induced alveolar EMT.  In response to active TGF , 
alveolar epithelial cells have been shown to form complexes of E-cadherin, TGF  
receptors, and 3 1 integrins which then go on to generate phospho-Smad2(p-Smad2)-
pY654- -catenin complexes.  These p-Smad2-pY654- -catenin complexes then 
translocate to the nucleus and through some unknown mechanism upregulate EMT-
related mesenchymal genes.  Presumably if 3 1 is otherwise engaged, such as in 
binding to an extracellular matrix ligand or in complexes with E-cadherin in adheren 
junctions, then it cannot form complexes with E-cadherin and TGF  receptors, therefore 
preventing EMT. (85)  Preferential binding of 3 1 to “unstrained”, and, therefore, more 
compact, Fn could then potentially regulate activation of TGF  through these or other 
unknown mechanisms.  The first two aims of this project investigate whether force-
mediated unfolding of Fn domains modulates ATII cell 3 integrin engagement and the 
downstream consequences of 3 1-Fn engagement relative to TGF  activation, 
signaling, and subsequent EMT. 
Mechanotransduction:  Cells and Stiffness 
The composition of the extracellular matrix surrounding a cell has great consequences on 
cell fate; however, evidence is mounting that, in addition, cells sense and respond to the 
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mechanical properties of the ECM, particularly the stiffness of the matrix.  The process of 
cellular sensing of the underlying properties of the ECM has been termed 
mechanotransduction.  Matrix stiffness has been shown to influence many aspects of 
cellular behavior including stem cell, myoblast, and breast epithelial cell differentiation; 
cellular motility; contractility; and focal adhesion formation, and it has also been shown 
to contribute or prevent a malignant phenotype. (86-94) Reports by Engler et al. showed 
that stem cell differentiation can be guided by underlying matrix mechanics, with 
mesenchymal stem cells on hard substrates differentiating down an osteoblastic lineage 
and mesenchymal stem cells on soft substrates differentiating down a neuronal lineage, 
which suggests a potential mechanism through which stem cells “match” their 
differentiation based on the surrounding tissue.  Interestingly, as previously described, 
changes in tissue stiffness, specifically an increase in stiffness and hardening of tissue, is 
associated with the pathological progression of fibrotic responses.  Recent AFM analysis 
of fibrotic tissue from mice with bleomycin-induced pulmonary fibrosis shows a nine-
fold increase in stiffness of fibrotic tissue compared to that of normal tissue.  (95)  In 
addition, increases in tissue elasticity in pathological conditions of tumor formation and 
muscular dystrophy have been reported to be increases approximately nine-fold and 1.5-
fold, respectively.  (86, 88) 
Interestingly, it has recently been shown that mesenchymal cells respond to substrate 
stiffness by engaging their actinomyosin contractile machinery in a manner that 
facilitates cell-ECM compliance matching.   This has been demonstrated by AFM 
analysis of single cell stiffness, showing fibroblasts become increasingly stiff on 
increasingly rigid substrates, indicating a cell may adjust its internal stress through 
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contraction to “match” its external environment. (94)  As a consequence of this mechano-
homeostasis between the cell and its ECM, cells in increasingly rigid, or stiff, 
environments display increased activation of contractile signals like Rho and Rho 
associated kinase (ROCK), resulting in multiple and diverse secondary effects.  An 
elegant example of this is shown by Wipff et. al. who demonstrated that fibroblast 
activation of TGF  increases on increasingly rigid substrates, leading to greater 
myofibroblast differentiation on stiff, but not compliant, substrates. (96)  Because fibrotic 
diseases are characterized by increased tissue stiffness, and because of TGFβ‟s prominent 
role in the onset of EMT, it was hypothesized that a similar mechanism of increased 
TGFβ activation with increasing stiffness would contribute to EMT on increasingly rigid 
substrates.      
While many studies have shown the important role of mechanical properties in 
influencing cell phenotype, little is known about how a cell actually senses mechanical 
properties.  Because of their role in ECM ligand interactions, it is hypothesized that 
integrins play a critical role in mechanotransduction, (97-99) but how integrins interact 
with specific extracellular ligands to determine transduction of matrix mechanical 
properties is not well understood.  Integrin binding to an ECM ligand can result in 
physical linkage between integrin and the cytoskeleton, allowing force transmission 
through the attachment site and reinforcement of the protein complex. (93, 100)  Force 
application to the focal adhesion complex leads to recruitment and activation of signaling 
proteins like FAK, Src, and Shc whose major downstream targets are Rho GTPases.  
Importantly, activation of the Rho signaling cascade leads to cytoskeletal rearrangement 
and increased cell contractility, having numerous influences on cell phenotype, and 
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implications in EMT, by potentially increasing TGFβ activation. (101, 102)  In addition, 
differential integrin binding to Fn can lead to differences in adhesion dynamics and 
adhesion reinforcement. (103, 104) Recent reports by Rosa-Cusachs et al. reported 
dynamic stiffening of the attachment site when physiological forces were applied via 
mainly v 3, whereas binding and clustering of 5 1 resulted in enhanced adhesion 
strength, indicating v 3 integrins may play a key role mechanotransduction. 
While the precise mechanism of cell stiffness sensing remains unknown, it likely 
involves the binding of specific integrins that result in transduction of stiffness-mediated 
signaling via increased cell contractility.  This dissertation explores the role of two 
mechano-transduction events in the onset and progression of EMT:  1) the role of Fn 
conformation changes, such as those that arise from molecular unfolding, in integrin 
specific binding and downstream EMT and 2) the role of substrate stiffness in Fn-
mediated EMT.  These studies provide insights into the role of mechanotransduction in 
the onset and progression of fibrotic pathologies. 
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INTEGRIN SPECIFIC RESPONSES TO FIBRONECTIN TYPE III 
DOMAINS DETERMINE EPITHELIAL TO MESENCHYMAL 
TRANSITIONS (EMT) * 
Introduction 
 The extracellular matrix (ECM) provides important directional cues for 
directing cellular processes, such as cell spreading, survival, proliferation, and 
differentiation.  In pathological states such as fibrosis where the ECM has become 
modified, either in composition or in mechanical properties, cells are forced into a non-
homeostatic niche, and the ECM can facilitate altered and potentially pathological 
phenotypes, such as epithelial to mesenchymal transitions.  
Cells interact with their underlying ECM through transmembrane cell-surface 
receptors known as integrins, heterodimeric molecules comprised of transmembrane 
alpha and beta subunits, which are intracellularly linked to cytoskeletal proteins such as 
talin, vinculin, and/or paxillin. (1)  Integrins bind to ECM molecules through specific and 
often multiple synergistic sequences on ECM proteins.  Likewise, ECM proteins often 
contain several distinct binding sites for multiple integrins and some individual integrin 
binding sequences within the ECM can bind multiple integrins.   
* Modified from: 
 
Brown AC, Rowe JA, Barker TH. Guiding epithelial cell phenotypes with engineered 
integrin-specific recombinant fibronectin fragments. Tissue Eng Part A.17:139-50. 
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As a result, cells can exhibit different phenotypic responses to the same ECM molecule 
depending on the integrins that bind, (2, 3) which is in turn directed not only by cellular 
expression of particular integrins but also by the conformation of the ECM ligand, the 
availability of specific ligand sequences, and the avidity of particular integrins to 
competing sites of engagement.  ECM-integrin interactions are of particular interest in 
dynamic ECMs, such as those observed in development and wound healing, because if 
not precisely controlled, alterations in these interactions can lead to pathological 
conditions.   
As a part of their normal function in tissue development, repair, and remodeling, 
epithelial cells must display two distinct phenotypes, namely an epithelial phenotype 
characterized by tight cell-cell junctions and formation of „high resistance‟ epithelial 
sheets, as determined by resistance to electrical current, (4) and  a mesenchymal-like 
phenotype characterized by migratory/invasive behavior and ECM production. (5, 6)  The 
processes of these phenotypic conversions are termed epithelial to mesenchymal and 
mesenchymal to epithelial transition (EMT and MET, respectively).  Normal phenotypic 
switching associated with EMT and MET as a part of development, repair, and 
remodeling is not often associated with a complete and permanent conversion and thus is 
often referred to as partial-EMT or MET. (7-9)  However, if chronically stimulated, 
epithelial cells are capable of a complete conversion to mesenchymal or fibroblastic 
phenotypes, such as in the case of metastatic cancer and fibrotic pathologies. (10, 11)  In 
particular, complete EMT further perpetuates fibrotic responses by increasing the number 
of synthetic, ECM producing fibroblasts.  Thus, the process of EMT and MET must be 
tightly regulated during normal events such as re-epithelialization. 
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Re-epithelialization during wound healing, and the phenotypic switching essential 
to this process, has been shown to be promoted by binding of specific integrins to ECM 
molecules, such as Fn, including but not limited to 5 1, 3 1, and 2 1. (12, 13)  For 
example, re-epithelization of airway epithelial cells has been shown to be modulated by 
binding of 5 1 integrin to Fn. (12)  On the other hand, engagement of other integrins 
associated with wound-healing, including the RGD-binding integrins v 3, v 5, v 6, 
and v 8 (13) have been associated with greater induction of EMT, through activation of 
cell contractile machinery, enhanced migration, and contraction.  Interestingly, Fn has the 
capacity to interact with integrins that promote re-epithelization as well as those that have 
been shown to induce EMT.  Integrin mediated activation of cell contractility has 
significant consequences to the force-mediated activation of the fibrogenic cytokine 
TGF . (14-17)  The activation of TGF  can be induced by contractile cells through 
mechanical release of TGF  from the inactive complex leading to further enhancement of 
the EMT process and downstream cell contraction and ECM production.  (10)  While 
induction of cell contractility/mobility is critical for proper wound-healing, there is a 
critical balance that must be achieved in order to direct regeneration or formation of 
epithelial tissues without inducing fibrotic responses.  The goal of this aim is to 
understand how integrin specific binding to recombinant Fn fragments modulates normal 
wound healing or EMT responses.  Significant research has demonstrated that Fn has the 
capacity to bind many of the integrins involved in re-epithelization and wound repair, 
including v 3, v 6, 3 1, and 5 1, (12, 18-21) and could therefore direct 
differential cellular responses depending on specific integrin engagement.  
 - 39 -   
Fn, a soluble dimeric glycoprotein consisting of two nearly identical monomers 
approximately 250 kD in size, is comprised of three repeating subunits known as type I, 
type II, and type III repeats.  (20)  The central cell binding domain of Fn, where most 





 type III repeats contain the integrin binding “synergy” site 
(PHSRN) and RGD sequences, respectively. (22, 23)  Recently, the relative position of 
these two binding sites on adjacent type III repeats has been shown critical for 5 1 
integrin binding, such that 5 1 binding is nearly abolished in the absence of the synergy 




 type III 
repeats and the reliance of 5 1 integrin binding to the synergy sequence, recombinant 




 type III repeats (PHSRN and 
RGD sites) containing a point mutation previously shown to stabilize the relative position 
of these two domains, (24, 30) or the 10
th
 type III repeat alone to direct integrin binding.  
Based on Fn's known role in directing re-epithelialization (12) and/or EMT (10), it was 
hypothesized that the presence of the synergy site is critical to the regulation of epithelial 
cell phenotype, by directing integrin specificity.  Here, utilizing engineered recombinant 
fragments of Fn to model two conformation of the molecule, the role of Fn conformation 
in directing epithelial attachment via v, 3, and 5 integrins and the resulting 
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Figure 3.1:    Schematic of recombinant fibronectin (Fn) fragments.  FnIII10 contains 
only the Arg-Gly-Asp (RGD) site and is expected to interact with predominantly v 
integrins and direct epithelial cells to undergo epithelial-to-mesenchymal transition. 
FnIII9‟10 contains both the RGD and Pro-His-Ser-Arg-Asn (PHSRN) sites and is 
expected to interact predominantly with the 5 integrin subunit and direct epithelial cells 







Materials and Methods 
Production of recombinant proteins 
  Recombinant Fn fragments were produced as previously described. (30)  Briefly, 




 type III repeats with a structural stabilizing 
Leu
1408
 to Pro point mutation (FnIII9‟10 (24)) and the 10
th
 type III repeat alone (FnIII10) 
were transformed into BL21 E.coli and Fn fragments purified by GST affinity 
chromatography (AKTA Purifier, GE Healthcare, Piscataway, NJ, USA). GST tags were 
removed using bovine thrombin (Sigma–Aldrich, St. Louis, MO, USA), and proteins 
were verified as >98% pure by SDS-PAGE.  
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Cell culture  
RLE-6TN cells, an alveolar epithelial cell line, were obtained from ATCC 
(Manassas, VA, USA) and maintained in DMEM/F12 media supplemented with 10% 
FBS, 1% P/S.  For experiments analyzing the role of Fn fragments in directing cell 
phenotype, cells were plated on 2 M Fn-fragment coated, 1% heat denatured (hd)-BSA 
blocked plates and cultured in serum-free DMEM/F12 media.  
Attachment assay 
 Cell attachment assays were performed as previously described. (32)  Briefly, 
surfaces were coated with 2 M (30) Fn fragments (FnIII9‟10 and FnIII10 have similar 
coating efficiencies (33)) and blocked with 1% hd-BSA.  RLE-6TN cells were incubated 
with 5 g/mL anti- 3 (Ralph 3.2), anti- v (H9.2B8), anti- 5 (HM 5-1) (Santa-Cruz 
Biotech, Santa Cruz, CA, USA), anti- 1 (HM 1-1), or anti- 3 (2C9.G2) (Biolegend, San 
Diego, CA, USA) function blocking antibodies or normal mouse IgG control (Millipore) 
or with 1 g/mL synergy, RGD, synergy plus RGD, or control scrambled peptides 
(Anaspec, Fremont, CA, USA) for 30 minutes at 37 C in serum-free DMEM/F12 media.  
A concentration of 5 g/mL was used for antibody blocking experiments based on dose 
response experiments demonstrating that this concentration was saturating for all 
antibodies utilized.  Cells were allowed to attach for 20 minutes at 37 C, washed to 
remove unbound cells, fixed, and stained with crystal violet and absorbance quantified at 
570 nm. Attachment values were normalized to cell attachment levels on hd-BSA (0% 
attachment) and to the test fragment with cells incubated with the IgG control or the 
scrambled peptide control (100% attachment).  Data from triplicate experiments were 
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normalized and presented as averages +/- standard error.  Both normalized (left) and total 
cell number (right) are presented on the y-axis.  
Immunofluorescence integrin staining 
 RLE-6TN cells were cultured on 2 M FnIII9‟10 or FnIII10 coated, hd-BSA blocked 
glass coverslips for 3 hours. Cells were washed with PBS, fixed with 4% formaldehyde, 
permeabilized with 0.2% Triton-X 100 and then blocked with 10% goat serum.  Primary 
antibodies were incubated for 1 hour then washed thoroughly with PBS + 0.2% Tween-
20. Integrin 3, 5, and v antibodies utilized for attachment assays were also utilized 
for immunofluorescence as recommended by the manufacturer. Secondary antibodies 
(Alexa-Fluor-488 goat-anti-mouse, Invitrogen; FITC-conjugated goat anti-Armenian 
hamster, Santa-Cruz Biotech) were incubated for 1 hour then washed thoroughly with 
PBS + 0.2% Tween-20.  Nuclei were stained with Hoescht (Invitrogen), coverslips 
mounted for imaging, and images acquired with a Nikon Eclipse (TiE) inverted 
fluorescence microscope at 100X magnification, (100X, PlanApo 1.4 NA oil-immersion 
objective) with a CoolSNAP HQ2 Monochromatic CCD camera.  Experiments were 
performed in triplicate, and images presented are representative from at least 5-10 
random fields for each independent experiment.  
Analysis of gene expression 
 RLE-6TN cells were cultured on plates coated with 2 M Fn fragments and blocked 
with hdBSA.  Epithelial cells were cultured in serum free DMEM/F12 media for 48 
hours.  For analysis of Pai-1, cells were cultured in the absence or presence of 5 ng/mL 
active TGF  (R&D Systems, Minneapolis, MN) or 10 g/mL TGF  neutralizing antibody 
(9016, R&D Systems).  Cells were trypsinized, mRNA isolated (RNAeasy, Qiagen, 
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Valencia, CA, USA) and c-DNA generated (High Capacity cDNA Reverse Transcription 
Kit, Applied Biosystems, Foster City, CA, USA).  Primers (Invitrogen, Carlsbad, CA, 
USA) used for q-PCR reactions were as follows: -SMA forward 
TTCGTTACTACTGCTGAGCGTGAGA; -SMA reverse 
AAAGATGGCTGGAAGAGGGTC (34); collagen I forward 
GGTAACGATGGTGCTGTCGG; collagen I reverse GGGACCTTGAACTCCAGCAG 
(35); GAPDH forward GGCAAGTTCAATGGCACAGT; GAPDH reverse 
AAGGTGGAGGA ATGGGAGTT (35); ZO-1 forward 
TCAGATCCCTGTAAGTCACC; ZO-1 reverse CCATCTCTTGCTGCCAAAC (36); N-
cadherin forward AGGGCCTTAAAGCTGCTGACA; N-cadherin reverse 
TCATAGTCGAAGACTAAAAGGGAGTCATAT (37); Vimentin forward 
CCCAGATTCAGGAACAGCAT; Vimentin reverse CACCTGTCTCCGGTATTCGT 
(designed using Primer3Plus software); E-cadherin forward 
TGAGCATGCCCCAGTATCG ; E-cadherin reverse CTGCCTTCAGGTTTTCATCGA 
(37); Plasminogen activator inhibitor-1 (Pai-1) forward 
CACAGTGCTGGGTGTAATGG; Pai-1 reverse GTTTGTGGGGCAGCTATTGT 
(designed using Primer3Plus software). Q-PCR was performed on a Step One Plus ABI 
thermocycler (Applied Biosystems) using Power SYBR Green Master Mix (Applied 
Biosystems).  Data was analyzed using the ∆∆CT method using GAPDH as the 
endogenous control and comparing expression levels to cells cultured on FnIII9‟10.  Q-
PCR reactions were run in triplicate and performed for 3 independent experiments.  Data 
shown was pooled from 3 independent experiments.   
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Immunofluorescence E-cadherin/ -SMA staining 
 RLE-6TN cells were cultured on 2 M Fn fragment-coated, hd-BSA blocked glass 
coverslips for 48 hours in the absence or presence of 5ng/mL active TGF .  Cells were 
processed as described for integrin staining with the exception of using anti-E-cadherin 
(36/E-Cadherin; BD Transduction Laboratories, San Jose, CA, USA)) and anti- -SMA 
(1A4, Sigma-Aldrich) antibodies. Alexa-Fluor-488-conjugated goat-anti-mouse 
(Invitrogen) was used as the secondary antibody.  Images were acquired with a Nikon 
Eclipse (TiE) inverted fluorescence microscope at 20X magnification (PlanFluor 20X, 
0.5 NA objective) with a CoolSNAP HQ2 Monochromatic CCD camera.  Experiments 
were performed in triplicate, and images presented are representative from 5-10 random 
fields for each independent experiment.  
Analysis of cell shape and cytoskeleton organization 
 RLE-6TN cells were cultured on FnIII9‟10 (2 M), FnIII10 (2 M), Fn (0.1 M), or 
Ln (0.1 M) coated, hd-BSA blocked coverslips in serum-free DMEM/F12 media in the 
absence or presence of 5 ng/mL activated TGF  for 48 hours and fixed with 4% 
formaldehyde. The concentration of Fn was chosen based on previous studies showing 
similar binding of an antibody specific to the 7-10 type III repeats of Fn (clone 
HFN7.1a1) (30) to Fn and the Fn fragments at 2 M concentrations, and the 
concentration of Ln was chosen based on ELISAs showing maximal coating at 0.1 M. 
Actin was stained with Texas-red phalloidin (Invitrogen) and nuclei were stained with 
Hoescht stain (Invitrogen).  Coverslips were mounted and images acquired with a Nikon 
Eclipse (TiE) inverted fluorescence microscope at 100X magnification (PlanApo 100X, 
1.4 NA oil-immersion objective) with a CoolSNAP HQ2 Monochromatic CCD camera.  
 - 45 -   
Representative images are presented.   
Analysis of circularity  
 Cells were cultured on FnIII9‟10 (2 M), FnIII10 (2 M), Fn (0.1 M), or Ln (0.1 
M) for 48 hours in the absence or presence of 5ng/mL active TGF  and the cytoskeleton 
visualized as described above. Area and perimeter of individual cells was determined for 
each condition using Image J (NIH Freeware) image processing software, then circularity 
was determined using the equation circularity = 4π(area/perimeter
2
).   Three independent 
images were analyzed for each condition, and at least 10 cells were analyzed per image.  
Data is pooled from all 3 images analyzed per condition. 
Wound-healing assay   
 Wells of 24-well plates were coated with FnIII9‟10 (2 M), FnIII10 (2 M), Fn 
(0.1 M), or Ln (0.1 M) and then blocked with hd-BSA.  Cyto-select wound healing 
inserts (900 m wide, Cell Biolabs, Inc, San Diego, CA, USA) were then placed in coated 
wells and RLE-6TN cells seeded at 200,000 cells/cm
2
 in serum-free DMEM/F12 media.  
To insure even distribution of cells, half of the cell suspension was plated on each side of 
wound field insert.  Cells were allowed to form a monolayer for 5 hours, which was 
verified by phase contrast.  The wound insert was then removed, cells were gently 
washed with PBS to remove any unattached cells, and media was replaced with fresh 
serum-free DMEM/F12 in the absence or presence of 5ng/mL active TGF .  Cells were 
allowed to migrate and close the wound field for 15 hours, followed by gentle washing 
2X with PBS, fixation and nuclei staining with DAPI (Cell Biolabs) and immediate 
imaging. At least 3 images were taken per condition, and conditions were run in 
triplicate.  Percent wound closure was determined by measuring the wound gap area, 
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dividing by original wound area, and multiplying times 100%.   
Statistical analysis  
 
All statistical analysis was performed by multi-variate ANOVA using Prism 





Fn fragments induce integrin specific adhesion 
To determine if the presence/absence of the synergy site in concert with the 
RGD site affects epithelial cell integrin binding to Fn type III repeats, a series of 
attachment assays were performed with a number of integrin function blocking 
antibodies.  The integrins analyzed were chosen because they are known to be 
expressed by RLE-6TN cells and also are reported to bind Fn.  Attachment of epithelial 
cells to FnIII9‟10 was particularly sensitive to anti- 3, anti- 5, and anti- 1 function-
blocking antibodies and less so to anti- v and anti- 3 antibodies.  Epithelial cell 
attachment to FnIII9‟10 was inhibited by 80% (p<0.01 with respect to IgG control) in 
the presence of 3 function-blocking antibodies, 105% (p<0.001 with respect to IgG 
control) in the presence of 5 function-blocking antibodies, and 90% (p<0.001 with 
respect to IgG control) in the presence of 1 function-blocking antibodies.  Contrary to 
epithelial cell binding to FnIII9‟10, adhesion to FnIII10, which only contains the 
integrin-binding RGD sequence but not the adjacent synergy motif (PHSRN) on FnIII9, 
was less integrin specific and was most notably inhibited by anti- v integrin antibodies.  
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RLE-6TN cells demonstrated a 40% inhibition of binding to FnIII10 in response to 
anti- v antibodies, while anti- 3, anti- 5, and anti- 1 antibody had negligible effect 
(Figure 3.2A-B). These data indicate that while epithelial cells are capable of binding 
the RGD motif when it is decoupled from the synergy motif, binding via 3, and 
predictably 5, integrins require the two motifs‟ synergistic activity and thus proper 
orientation.  
To determine whether the synergy and RGD sites specifically contribute to epithelial cell 
binding to FnIII9‟10 fragments, attachment assays were also performed with epithelial 
cells preincubated with soluble RGD and synergy mimetic peptides. Attachment values 
were normalized to the controls (100%, scrambled peptide; 0%, hd-BSA) and both 
normalized and total cell number presented on the y-axis (Figure 3.2C-D). Attachment of 
cells to FnIII9‟10 was particularly sensitive to both RGD and PHSRN (synergy) peptides, 
with adhesion inhibited 63% (p<0.05) and 79% (p<0.01), respectively.  Adhesion to 
FnIII9‟10 was blocked most significantly with a combination of RGD and PHSRN 
peptides where adhesion was inhibited 122% (p<0.001).  Contrary to the binding of 
FnIII9‟10, adhesion to FnIII10 was most notably blocked by RGD peptides, with 
adhesion inhibited 46%, while PHSRN peptides had no considerable effect.  In addition, 
the combination of RGD and PHSRN peptides showed approximately the same level of 
inhibition as RGD peptides alone, with adhesion inhibited 48%. 
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Figure 3.2:  Attachment of RLE-6TN cells on Fn fragments.  Attachment of epithelial 
cells to FnIII9‟10 (A, C) or FnIII10 (B, D) fragments was analyzed +/- integrin function 
blocking (FB) antibodies (A-B) or +/- inhibitory peptides (C-D) through a standard 
attachment assay.  Percent attachment (left y-axis) was determined by normalizing 
attachment to BSA (0%) and Fn fragment in the presence of control IgG (A-B) or 
scrambled peptide (C-D) (100%) and averages and standard errors are plotted.  Total cell 
number is reported on the right y-axis.  *** denotes p < 0.001, ** denotes p <0.01, * 
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Specific integrin clustering is modulated by the Fn synergy site  
 To further characterize integrin specific responses to Fn fragments at early 
time points, RLE-6TN cells were cultured on Fn fragments for a period of 3 hours then 
stained for integrin subunits 3, 5, or v. These integrin subunits were chosen for 
staining based on the differences in integrin binding to Fn fragments as determined 
through the attachment assays.  Cells cultured on FnIII9‟10 displayed distinct and strong 
punctate staining for 3 and 5 integrins indicative of epithelial focal contact formation 
(Figure 3.3A, E), while cells cultured on FnIII10 displayed minimal staining for 3 and 
5 integrins (Figure 3.3B, F). In contrast, cells cultured on FnIII10 exhibited a stronger 
staining pattern for v integrins (Figure 3.3D).   Cells cultured on FnIII9‟10 displayed 
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Figure 3.3:  Integrin 3, v, and 5 surface expression and distribution. Cells were 
analyzed for 3 (A-B), v (C-D), and 5 (E-F) integrin surface expression and 
distribution by immunofluorescence 3 hours after plating cells on FnIII9‟10 (A, C, E) or 
FnIII10 (B, D, F). Images were acquired with a Nikon Eclipse (TiE) inverted 
fluorescence microscope at 100X magnification.   Images are representative of 3 
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Epithelial cells exhibit differences in expression of epithelial and mesenchymal specific 
genes when cultured on Fn fragments displaying both RGD and synergy versus RGD 
alone  
 To determine if differences in initial integrin engagement of Fn fragments induced 
changes in EMT-related response genes, RLE-6TN cells were cultured on FnIII9‟10 and 
FnIII10 for 48 hours in serum-free DMEM/F12 media, then expression of various 
epithelial and mesenchymal genes was determined by q-PCR (Figure 3.4).  All epithelial 
genes analyzed were significantly down-regulated in cells cultured on FnIII10 compared 
to cells cultured on FnIII9‟10, and all mesenchymal genes analyzed were up-regulated.  
Specifically, E-cadherin was down-regulated sevenfold (p<0.05), and ZO-1 was down-
regulated approximately twofold (p<0.05) in cells cultured on FnIII10.  In contrast, -
SMA was up-regulated 18-fold (p<0.001), vimentin was up-regulated 32-fold (p<0.001), 
N-cadherin was up-regulated 78-fold (p<0.001), and collagen I was up-regulated 
sevenfold (p<0.05) in cells cultured on FnIII10. 
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Figure 3.4:  Gene expression analysis.  RLE-6TN cells were cultured for 48 hours on 
Fn fragments (FnIII9‟10 and FnIII10), then RNA was isolated for gene expression 
analysis.  Levels of expression of epithelial (E-cad, ZO-1) and mesenchymal ( -SMA, 
Col I, Vimentin, N-cad) markers were determined by q-PCR.  Fold changes in gene 
expression were determined by CT analysis using GAPDH as the endogenous control 
and comparing expression to cells cultured on FnIII9‟10.  Reactions were performed in 
triplicate.   *** denotes p < 0.001, * denotes p <0.05 From (31) 
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Epithelial cells exhibit differences in E-cadherin and -SMA protein expression and 
localization when cultured on Fn fragments displaying both RGD And synergy versus 
RGD alone 
To characterize expression and cellular localization of select epithelial and 
mesenchymal proteins, RLE-6TN cells were cultured on FnIII9‟10 or FnIII10 in the 
absence (Figure 3.5A-B; E-F) or presence (Figure 3.5C-D; G-H) of 5 ng/mL active 
TGF  for 48 hours then stained for E-cadherin (epithelial marker) (Figure 3.5A-D) and 
-SMA (mesenchymal marker) (Figure 3.5E-H).  Cells cultured on FnIII9‟10 displayed 
strong staining for E-cadherin at cell contacts, characteristic of an epithelial phenotype, 
with additional punctuate staining throughout the cell (Figure 3.5A).  In contrast, 
epithelial cells seeded on FnIII10 displayed significantly less E-cadherin at cell-cell 
contacts, even after only 48 hours in culture (Figure 3.5B).  The presence of 5 ng/mL 
active TGF  drove similar E-cadherin staining patterns in epithelial cells regardless of 
the substrate, with some diffuse cell-cell contact staining and significant amounts of 
intracellular punctuate E-cadherin (Figure 3.5C-D).  In support of a loss of epithelial 
character, a significant number of epithelial cells cultured on FnIII10 displayed staining 
for -SMA (Figure 3.5F), while cells cultured on FnIII9‟10 displayed no detectable 
staining (Figure 3.5E).  As expected, cells cultured in the presence of TGF  displayed 
significant staining for -SMA regardless of underlying ligand (Figure 3.5G-H).  
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Figure 3.5: E-Cadherin and -SMA staining in RLE-6TN cells cultured on Fn 
fragments.  RLE-6TN cells were cultured on FnIII9‟10 (A, C, E, G) or FnIII10 (B, D, F, 
H) in the absence (A-B, E-F) or presence (C-D, G-H) of 5ng/mL active TGF  for 48 
hours.  Cells were then analyzed for E-cadherin (A-D) and -SMA  (E-H) expression and 
distribution via immunoflouresence staining. Fluorescent images were acquired with a 
Nikon Eclipse (TiE) inverted fluorescence microscope at 20X magnification.  Images are 
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Epithelial cells cultured on Fn fragments display different degrees of cytoskeletal 
organization   
 Next, cytoskeletal organization, stress fiber formation, and cell circularity were 
analyzed by culturing RLE-6TN cells for 48 hours on FnIII9‟10, FnIII10, Fn, or Ln in the 
absence (Figure 3.6A-D) or presence (Figure 3.6E-H) of 5ng/mL active TGF .  Cells 
were stained with Texas-red phallodin to visualize the actin cytoskeleton.  Cells cultured 
on FnIII9‟10 displayed a more rounded, cuboidal morphology and diffuse staining for 
actin (Figure 3.6A) similar to cellular responses to Ln (Figure 3.6D), while cells 
cultured on FnIII10 (Figure 3.6B) were more spread and displayed aligned, thick actin 
filaments characteristic of stress fibers similarly to cells cultured on full length Fn 
(Figure 3.6C).  The addition of TGF  enhanced actin filament alignment and stress fiber 
formation regardless of the adhesive ligand, with the exception of Ln which supported a 
more rounded epithelial phenotype (Figure 3.6E-H).  Cell circularity was calculated to 
quantify differences observed in cell shape (Figure 3.6I); values closer to 1 indicated a 
more rounded cell.  Cells cultured on FnIII9‟10 exhibited a circularity value of 0.61, 
compared to cells on FnIII10 which were quite spread and displayed a circularity of 0.26 
(p<0.001).  The addition of TGF  resulted in circularity values less than 0.35 on each 
substrate with the exception of Ln, which exhibited a circularity value of 0.47. The 
addition of TGF  to cells cultured on FnIII9‟10 significantly decreased the circularity to 
0.27 (p<0.001). 
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Figure 3.6:  Actin cytoskeleton alignment, stress fiber formation, and changes in cell 
circularity in response to Fn fragments.  RLE-6TN cells were cultured for 48 hours on 
FnIII9‟10 (A,E), FnIII10 (B, F), Fn (C, G), or Ln (D, H) in the absence (A-D) of 
presence (E-H) of 5ng/mL active TGF . To analyze stress fiber formation, the actin 
cytoskeleton was visualized by staining with Texas-red phalloidin and the nuclei stained 
with Hoescht. Images are of representative of at least 3 independent experiments.  Cell 
circularity was calculated to quantify differences observed in cell shape (I); values closer 
to 1 indicate a more rounded cell. Fluorescent images were acquired with a Nikon Eclipse 
(TiE) inverted fluorescence microscope at 100X magnification. Three independent 
images were analyzed for each condition and 10 cells were analyzed per image.  Data is 
pooled from all 3 images analyzed per condition.  *** denotes p<0.001 relative to cells 
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Epithelial cells exhibit differences in Pai-1 expression when cultured On FnIII10 
compared to cells cultures on FnIII9‟10  
 To determine if differences in initial integrin engagement of Fn fragments induced 
changes in Pai-1, a TGF -specific responsive gene, RLE-6TN cells were cultured on 
FnIII9‟10, FnIII10, Fn, or Ln for 48 hours in serum-free DMEM/F12 media in the 
absence or presence of 5ng/mL active TGF  or 10 g/mL TGF  inhibiting antibody and 
then expression of the Pai-1 gene was determined by q-PCR (Figure 3.7).  Pai-1 was 
significantly up-regulated in cells cultured on FnIII10 compared to cells cultured on 
FnIII9‟10, approximately twofold (p<0.05), and upon addition of active TGF , cells 
cultured on FnIII10 increased Pai-1 expression significantly (2.5-fold, p<0.001). This 
difference was negated upon the addition of TGF  inhibiting antibody.  Cells cultured on 
Fn up-regulated Pai-1 threefold compared to cells cultured on FnIII9‟10, while cells 
cultured on Ln had equivalent expression levels as cells cultured on FnIII9‟10.  Again, as 
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Figure 3.7:  Pai-1 gene expression analysis.  RLE-6TN cells were cultured for 48 hours 
on FnIII9‟10, FnIII10 (A), Fn, or Ln (B) in the absence or presence of 5ng/mL active 
TGF . Levels of expression of the TGF  responsive gene Pai-1 was determined by q-
PCR.  Fold changes in gene expression were determined by CT analysis using 
GAPDH as the endogenous control and comparing expression to cells cultured on 
FnIII9‟10.  Reactions were performed in triplicate.  *** denotes p < 0.001, * denotes p 
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Epithelial cells cultured on FnIII9‟10 close wound-gap better than cells cultured on 
FnIII10 in an in vitro wound-healing assay 
To determine the effect of the Fn synergy sequence on promoting wound healing 
and the utility of the engineered Fn fragments in directing epithelial cell physiology, a 
functional wound-healing assay was performed on FnIII9‟10 (Figure 3.8A, C) or FnIII10 
(Figure 3.8B, D) coated plates in the absence (Figure 3.8A-B) or presence (Figure 
3.8C-D) of 5ng/mL of active TGFβ.  Controls included RLE-6TN cells on Fn and Ln 
(Figure 3.8E-F).  Percent wound closure was quantified for each condition (Figure 
3.8G). FnIII9‟10, resulting in 62% closure, promoted significantly greater wound closure 
at 15 hours than FnIII10 (25%; p<0.001).  The addition of TGF  resulted in decreased 
wound closure on both FnIII9‟10 and FnIII10, but FnIII9‟10 continued to promote 
significantly greater wound closure compared to FnIII10 (36% and 15% respectively; 
p<0.001).  As expected, cells on Fn exhibited a high percentage of wound closure (70%), 
which was significantly higher than cells cultured on FnIII9‟10 (p<0.05).  Cells cultured 
on Ln displayed 51% wound closure, which was significantly less than cells cultured on 
FnIII9‟10 (p<0.001). 
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Figure 3.8:  Wound healing responses on Fn fragments. A wound healing assay was 
performed with RLE-6TN cells plated on FnIII9‟10 (A, C), FnIII10 (B, D) in the absence 
(A-B) or presence (C-D) of 5ng/mL active TGF .  Controls included cells plated on Fn 
(E) and Ln (F). Cells were allowed to form a monolayer around a wound field insert, 
which was removed 5 hours post-seeding.  Cells were allowed to migrate and close the 
wound field for 15 hours, then fixed and their nuclei stained.  Cells were imaged at 10X 
magnification. Percent wound closure was determined (G) by measuring the wound gap 
area and dividing by original wound area and multiplying by 100%.  At least 3 images 
were taken per condition, and conditions were run in triplicate. *** denotes p<0.001, * 
denotes p<0.05.  From (31) 
 




Figure 3.9: Formation of multicellular aggregate structures along the wound edge of 
RLE-6TN cells cultured on FnIII10.  A wound healing assay was performed with RLE-
6TN cells plated on FnIII10. Cells were allowed to form a monolayer around wound field 
inserts, which were removed 5 h post-seeding. Cells were allowed to migrate and close 
wound field for 15 h and then fixed, and nuclei stained. Cells were imaged at 10X 
magnification to the immediate left of the wound field. Image is representative.  From 
(31) 
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Discussion 
 Cell-integrin interactions play a critical role in directing cellular processes 
that contribute to wound healing and tissue regeneration. Understanding these  
interactions in cellular environments with dynamic and rapidly changing ECMs, as in the 
case of wound healing, is important in understanding pathological progression of fibrotic 
pathologies, as well as for tissue engineering applications that aim to promote normal 
healing after removal of scar tissue, directing cell fate in vitro, or directing epithelial 
wound healing after injury (e.g. to the lung, mucosal lining, skin, etc.).  Directing 
alveolar epithelial wound healing after lung injury, such as injury caused by particulate 
matter inhalation, is of particular interest because abnormal wound repair/EMT has been 
identified as one of the key pathologies in the development of pulmonary fibrosis (PF), a 
progressive and fatal lung disorder.  (38) While significant effort has been made to 
prevent pathology-associated epithelial cell behaviors, such as EMT, these fundamental 
epithelial transitions are central to proper repair and regeneration of most, if not all, 
epithelial tissues. Cell-integrin interactions have been shown to play a significant role in 
directing EMT events, which if uncontrolled can have deleterious consequences such as 
fibrotic progression seen in PF.  On the contrary, if controlled, directed EMT could have 
great potential for regenerative medicine purposes, for example in directing complex 
tissue formation from a single stem cell population. In this aim, it is demonstrated that 
epithelial cell integrin binding can be controlled through engineered Fn fragments 
displaying a synergy and RGD (FnIII9‟10), or RGD alone (FnIII10) which in turn leads 
to differences in EMT-related cellular responses.  Upon further investigation these 
fragments can be utilized to direct complex epithelial responses related to wound healing 
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and/or EMT.   
 First, it was confirmed that engineered Fn fragments can direct specific 
epithelial cell-integrin interactions; specifically, it was found that epithelial cell 
attachment to FnIII9‟10 is blocked significantly by integrin 3, 5, and 1 function-
blocking antibodies, while binding to FnIII10 is less specific but is affected most notably 
by integrin v function blocking antibodies (Figure 3.2A-B).  These data suggest that 
epithelial cells bind to FnIII9‟10 via 3 and 5 integrins and that both of these integrins 
may interact with Fn in a synergy dependent manner, an interpretation further supported 
by inhibition of epithelial cell attachment with soluble RGD and synergy mimetic 
peptides.  Because FnIII10 contains only the RGD site, known as a promiscuous partner 
to many integrins, it is not surprising that epithelial cell attachment to this fragment is 
less specific.  Although a multi-variate ANOVA showed no significant inhibition of 
adhesion to FnIII10 by any one function-blocking antibody, a simple Student‟s t-test 
between cells incubated with integrin v antibodies and the IgG control showed a 
significant difference between these two groups (p<0.05).  FACS analysis of initial 
integrin expression confirmed previous reports that the epithelial cells utilized in these 
studies (alveolar epithelial cells) express v integrins to a lesser extent than 3 or 5 
(21); therefore, the observation that v function blocking antibodies blocked attachment 
to FnIII10 to any observable degree suggests that this integrin likely plays an important 
role in binding to Fn‟s cell-binding domain when only the RGD site is available for 
binding, a result reported in numerous other studies.  (30, 39, 40)  The synergy-site 
dependence of 5 integrin has been well studied and was expected; however, the finding 
that 3 integrin binding to Fn may potentially be significantly enhanced by the presence 
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and spatial stabilization of the synergy site is a novel finding that will require additional 
studies to fully establish.  Integrin 3 1, typically thought of as a laminin receptor, has 
been shown to bind Fn (in an RGD-dependent fashion) as well as collagen, yet these 
reported binding events are still somewhat controversial. (18, 41)  Studies here with both 
soluble RGD and synergy mimetics, while not conclusive evidence for the synergy-
dependence of 3 and 5 integrins, when taken together with the function-blocking 
antibody data is suggestive that these integrins require the presence of synergy. 
 Epithelial cell integrin clustering to Fn fragments was further demonstrated 
through immunofluorescence staining for 3, 5, and v subunits.  The clustering of 
integrins is one of the first events that triggers integrin-specific signaling cascades and 
the staining for 3 and 5 integrins in epithelial cells cultured on FnIII9‟10 were 
indicative of integrin clustering and focal contact formation, (Figure 3.3A, E) whereas 
v integrin staining demonstrated much less pronounced staining (Figure 3.3C) in 
epithelial cells cultured on FnIII9‟10. This staining pattern suggests that although the 
cells express 3 and 5 integrins and that these integrins may be displaying some slight 
promiscuity, epithelial cells are not capable of engaging 3 or 5 integrins to any 
appreciable degree when interacting with RGD only (FnIII10).  In contrast, cells cultured 
on FnIII10 exhibited a stronger staining pattern for v integrins (Figure 3.3E) compared 
to epithelial cells cultured on FnIII9‟10.   Together, these data suggest that epithelial cells 
engage Fn with integrins differentially depending on the presentation of the RGD and 
synergy sequences. 
Investigating epithelial cell phenotypic markers, specifically EMT related genes 
and proteins, it was observed that cells displayed a more mesechymal phenotype when 
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cultured on FnIII10 compared to cells cultured on FnIII9‟10 (Figures 3.4-5).  The 
observed shift towards a mesenchymal phenotype on FnIII10 was further evidenced by 
stress fiber formation, a significant decrease in circularity (Figure 3.6), and an elongated, 
fibroblast-like morphology that was accompanied by the loss of cell-cell contacts as 
observed through E-cadherin staining. In contrast, cells cultured on FnIII9‟10 maintained 
expression of epithelial markers, cell-cell contacts, and displayed an epithelial-like 
morphology after 48 hours, suggesting that epithelial cell engagement of the synergy site 
of Fn may play an important role in the spatiotemporal control of EMT.   
 TGF  signaling has been strongly linked to EMT and thus TGF  responses were 
investigated through the analysis of Pai-1 mRNA expression, the up-regulation of which 
is primarily mediated through the TGF  receptor/Smad signaling pathway.  (42)  Data 
indicate a substrate dependent TGF  response (Figure 3.7) confirming previous reports 
that Fn and Ln instruct altered TGF  responses. (10)  As expected, the addition of 
exogenous active TGF  further enhanced the expression of Pai-1 while the addition of a 
TGF  inhibiting antibody resulted in a loss of substrate dependent difference.  These data 
indicate that the differences in epithelial cell phenotype on Fn fragments are potentially 
due, in part, to differences in TGF  activation or signaling or both.  
Finally, the functional/physiological consequences of epithelial cell integrin-
specific engagement to Fn fragments was demonstrated through an in vitro wound 
healing assay (Figure 3.8), which allow for the investigation of cell behavior indicative 
of enhanced wound repair, such as the ability to close cell monolayer gaps.  Integrin 
5 1‟s role in promoting wound healing has been well characterized (12, 13); therefore, 
it was expected that cells engaging 5 1 on FnIII9‟10 would have a greater capacity to 
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heal monolayer wounds than cells engaging v integrins on FnIII10.  One observation 
requiring significant additional characterization is that epithelial cells cultured on 
FnIII10, rather than displaying the expected migratory phenotype associated with EMT, 
displayed at least a partial loss of contact inhibition as evidenced by the formation of 
multicellular aggregate structures along the wound edge  (Figure 3.9).  Interestingly, the 
addition of TGF  resulted in a decrease in wound gap closure.  TGF ‟s role in wound 
healing is complex, both inhibiting proliferation and inducing EMT.  Previous reports 
indicate that TGF  inhibits epithelial wound closure, (43)  yet TGF  antagonists result in 
reduced in vivo scar/fibrosis. (44)  
While Fn fragments displaying RGD or RGD and synergy have previously been 
used to direct mesenchymal stem cell fate, (29) these results illustrate the utility of these 
fragments in directing epithelial integrin-specific attachment, integrin clustering, and, in-
turn, differences in cellular phenotype.  In addition, these studies demonstrate the 
physiological relevance of the synergistic activity of Fn‟s 9
th
 type III repeat (synergy site) 
in concert with the 10
th
 type III repeat (RGD motif) in directing epithelial cell phenotypes 
of relevance to tissue repair and underscore the necessity of understanding not only the 
role of specific ECM molecules in directing cell fate, but also the role of particular 
molecular states, for example compact vs. extended, in directing cell fate.  The use of Fn 
fragments modeling these two molecular states allows for greater control over integrin 
specificity and concomitant cell fate.  This aim illustrates that altered biochemical states 
of Fn, as might be observed in response to extremely contractile fibrotic myofibroblasts, 
can contribute to altered integrin binding and perpetuation of aberrant cell phenotypes 
such as chronic EMT.   
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CHAPTER 4 
INTEGRIN 3 1 BINDS FIBRONECTIN AND IS DEPENDENT ON 
THE 9
TH
 TYPE III REPEAT  
Introduction 
Cells interact with their surrounding extracellular matrix via transmembrane cell 
surface receptors, known as integrins.  Integrins are heterodimeric proteins consisting of 
one α subunit and one β subunit, which are known to form at least 24 unique 
heterodimers.  (1)  Integrin interactions with their extracellular matrix (ECM) ligands 
facilitate a host of cellular responses, including cell spreading, migration, proliferation, 
and differentiation, and can contribute to more orchestrated cellular events, such as 
development and wound healing, by contributing to angiogenesis and epithelial to 
mesenchymal transitions.    Integrin binding to ECM ligands occurs through specific 
binding sequences, the most notable of these sequences being Arg-Gly-Asp (RGD), 
which is found on a large number of ECM proteins, including fibronectin, vitronectin, 
osteoponin, laminin, thrombospondin, and several others. (2)  Furthermore, integrin 
heterodimers can interact with multiple ECM ligands and bind to multiple binding 
sequences.  (3, 4)    
Fibronectin is a widely expressed extracellular matrix protein and is known to 
bind at least 16 integrins.  Biochemically, Fn exists as a soluble dimeric glycoprotein 
composed of two nearly identical 230-270 kDa monomers linked covalently near their C- 
termini by a pair of disulfide bonds. (5, 6)  Each monomeric subunit consists of three 
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types of repeating modules, type I, II, and III. These modules comprise functional 
domains that mediate interactions with other ECM components, cell surface receptors, 
and Fn itself. (6)  Whereas type I and II repeats are structurally stabilized with two 
intrachain disulfide bonds in each repeat, type III repeats have no disulfide bonds and, 
therefore, are highly sensitive to force-mediated unfolding, resulting in alterations of 
conformation of the molecule.  (5, 7, 8) Interestingly, a large number of Fn/integrin 
interactions occur through the RGD site, which is located on the 10th type III repeat. The 
recognition of this simple tripeptide sequence can be quite complex and greatly depends 
on flanking residues, its three dimensional presentation, and individual features of the 
integrin-binding pockets. This is most well characterized in α5β1 integrin binding to Fn, 
in which RGD in concert with a second recognition sequence (PHSRN), the so-called 
“synergy” site, in the adjacent 9th type III repeat is known to promote the specific 
interaction of α5β1 integrin binding to Fn through interactions with the α5 subunit. (9, 
10) The synergy site is located approximately 32 Å from the RGD loop on the 10
th
 type 
III repeat.  The type III repeats show great elasticity in the loops between their F- and G-β 




 type III repeats to present 
multiple conformations.  Under small applied forces (on the order of 10 pN) Fn‟s 10th 
type III repeat is susceptible to partial unfolding, resulting in an intermediate state in 
which the RGD loop within the 10
th
 type III repeats begins to translocate away from the 
9
th
 type III repeat, resulting in an increase in the distance between the RGD and synergy 
sites from approximately 32 Å to approximately 55 Å. (11)  This capacity to present 




 type III repeats has great implications on 
cell binding because the relative positioning of these two domains has been shown to 
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influence integrin α5β1 binding.  Integrin α5β1 binds by simultaneously engaging the 
RGD and synergy sites.  As these sites translocate away from one another, they can no 
longer be bound simultaneously, and integrin α5β1 no longer binds.  These findings 
suggest that an integrin “switch” can be mechanically induced by stretching and partially 
unfolding these two domains.  Further evidence suggesting that a mechanically induced 




 type III repeats of Fn was shown by studies 




 type III repeats, 
resulting in modulation of integrin specificity.  In these studies, the 9
th
 type III repeat was 
stabilized via a Leu-Pro mutation at amino acid 1408, (12, 13) or the 10
th
 type III repeat 
(14) was stabilized through stabilization of the hydrogen bonding within the repeat.  In 
both cases, stabilization of the relative positions of the two repeats resulted in increased 
affinity for integrin α5β1 over integrin αvβ3.  In addition, studies in which the linker 




 type III repeats was increased in length showed reduction 
in α5β1 binding. (15) 
 As reported in the previous aim, α3β1 binding to Fn may also be promoted by the 
9th type III repeat.  (16)  Using recombinant Fn fragments displaying the RGD and 
synergy sites with a stabilizing (L1408-P) point mutation (FnIII9‟10) or RGD alone 
(FnIII10), it was previously demonstrated that the presence of Fn‟s synergy site enhances 
epithelial cell integrin specificity; epithelial cell binding to FnIII9‟10 was significantly 
inhibited by anti- 3 and anti- 5 antibodies (p<0.01), while their inhibition of cell 
binding to RGD only Fn fragments was negligible. Additionally, epithelial cells seeded 
on FnIII9‟10, but not FnIII10, formed 3 and 5 integrin clusters. 
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Though the classical ligand for integrin α3β1 is laminin (Ln) (17, 18) it has been 
reported to bind collagen and Fn (6, 19, 20) and facilitate cell-cell interactions through 
both homophillic binding and binding to E-cadherin (21-23) Furthermore, integrin α3β1 
binding to Fn has been shown to occur in an RGD dependent fashion, however, α3β1 
binding to Ln and collagen does not occur through RGD sites.  Integrin α3β1 is highly 
expressed by many epithelial cells, including alveolar epithelial cells, renal epithelial 
cells, and keratinocytes, and has been shown to be critical for regulation of epithelial 
phenotype.  (24, 25)  Integrin α3β1 plays a critical role in maintaining epithelial integrity 
and facilitating wound repair responses, and, if not bound to its extracellular matrix 
ligands, it can contribute to pathologies such as EMT. (24, 26)  During wound healing 
responses, the ECM rapidly undergoes changes in composition from mostly Ln and 
elastin to higher concentrations of provisional matrix components, such as Fn.  
Understanding the ability of integrin α3β1 to bind to both its classical ligand Ln as well 
as Fn is important to understand cell interactions with these dynamic matrices observed 
in wound healing and may elucidate mechanisms involved in normal vs. pathological 
wound healing responses.      
Based on results reported in the previous aim that α3β1 binding to Fn may be 
promoted by the 9th type III repeat and other‟s reports that α3β1 binding to Fn is RGD 
dependent, it was hypothesized that α3β1 binding to Fn is enhanced by the presence of 
the 9
th
 type III repeat.  To explore this hypothesis, a variety of recombinant FnIII9‟10 
variants were created displaying i) a dominant negative R-A mutation in the synergy site 
(FnIII
9R-A
10), ii) a 2xG insertion in the linker region (FnIII9
2G
10), or iii) a 4xG insertion 
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in the linker region (FnIII9
4G
10) and surface plasmon resonance (SPR) was utilized to 
determine binding kinetics of integrin 3 1 to the Fn fragments. 
 
Materials and Methods 
Construction of mutant pGEX4T1-FnIII9-10 clones 
Cloning of the wild type FnIII9-10 was performed as previously described.  A 
Leu1408 to Pro mutation (FnIII9‟10) was made using the pGEX4T-1-FN III9-10 plasmid 
as previously described.  (12, 13, 16)  FnIII9‟10 variants displaying i) a dominant 
negative R-A mutation in the synergy site (FnIII
9R-A
10), ii) a 2xG insertion in the linker 
region (FnIII9
2G
10), or iii) a 4xG insertion in the linker region (FnIII9
4G
10) were then 
created using the QuikChange® II-E Site-Directed Mutagenesis Kit (Stratagene, La Jolla, 
CA). Sequences are presented in Table 4.1.  All plasmids were introduced to and 
maintained in the electro-competent XL-1 Blue E.coli strain provided and cultured in LB 
+ ampicillin plates at 37°C. Plasmids were extracted from cultures using the QIAquick 
Spin Miniprep Kit (QIAGEN, Valencia, CA) and verified via sequencing (Johns Hopkins 
Synthesis & Sequencing Facility, Baltimore, MD). 
Expression and purification of recombinant FnIII9‟10 proteins 
 Recombinant Fn fragments were produced as previously described. (13, 16)  
Briefly, the expression vectors described above were transformed into BL21 E.coli, cells 
were grown to the exponential growth phase and treated with IPTG for 3 hours.  Cells 
were then lysed by the addition of 10mg/ml lyzozyme and sonication, followed by  
incubation with 1% triton X-100 and 10U/ml of DNAse I.  Fn fragments were purified by 
GST affinity chromatography (AKTA Purifier, GE Healthcare, Piscataway, NJ, USA).  
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GST tags were removed using bovine thrombin (Sigma–Aldrich, St. Louis, MO, USA).  
A second round of purification was performed using GST and serine protease affinity 
chromatography to remove cleaved GST tags and thrombin.  Proteins were verified as 
>98% pure by SDS-PAGE.   
 
Surface plasmon resonance studies 
The Biacore 2000 (Biacore Lifesciences, GE Healthcare) was used to investigate 
kinetic binding constants (ka and kd) of Fn fragments variants for integrins α3β1, α5β1, 
and αvβ3. Briefly, integrins α3β1, α5β1, or αvβ3 (R&D Systems, Minneapolis, MN, 
USA) were covalently immobilized to gold-coated SPR sensor chips via self-assembled 
monolayer surface chemistry to generate a non-fouling surface with a controlled density 
of reactive carboxylic acid groups. Mixed self-assembled monolayers were generated on 
gold-coated chips as previously described (27, 28) by incubating with a 10:1 mixture of 
1-mM of tri(ethylene glycol)–terminated alkanethiols (HS-(CH2)11–(OCH2CH2)3–OH 
(ProChimia, Gdansk, Poland) and carboxylic acid–terminated alkanethiols (HS-
(CH2)11–(OCH2CH2)6–OCH2COOH) overnight. The senor chip was then loaded into 
the Biacore 2000 and the carboxylic acid–terminated alkanethiol surfaces was activated 
by flowing 200mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (Sigma-Aldrich) 
and 50mM N-hydroxysuccinimide (Sigma-Aldrich; 5µL/minute for 10 minutes). 
Immediately after activation, 3 1, 5 1, or v 3 integrins (100µg/ml) were 
immobilized at a flow rate of 5µL/minute for 10 minutes to achieve approximately 1500 
resonance units (1 resonance unit ~ 1 pg/mm2).  An additional channel was immobilized 
with BSA to serve as a reference channel; BSA (100ug/ml) was immobilized to achieve 
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approximately 1500 resonance units. Immobilization of integrins and BSA were 
performed in 0.1M sodium acetate, pH4.5.  Unreacted N-hydroxysuccinimide groups 
were quenched in all flow cells with 1M ethanolamine, pH 8.5 (10 µL/minute for 10 
minutes). Upon stabilization of the baseline signal, kinetic binding experiments were run 
in duplicate with Fn fragments, full length Fn, or Ln as the flow analytes.   Various 
concentrations for each Fn fragment (10µM-1nM) were flowed at 30µL/minute for 5 
minutes immediately followed by a 10-minute dissociation phase. Binding experiments 
were performed in 10mM HEPES, 150mM NaCl, 0.0001% Triton-X 100, and 2mM each 
MgCl2 and MnCl2, pH 7.4.  Experiments to determine the role of divalent cations in Fn 
fragment/ 3 1 integrin interactions were performed in 10mM HEPES, 150mM NaCl, 
0.0001% Triton-X 100, and 2mM EDTA.  Between each injection, the surface was 
regenerated with two 30 second pulses (10µL/minute) of 20mM EDTA and 1M NaCl 
(pH6.0).  At least two independent SPR experiments were performed with varying Fn 
fragment injection order to rule out binding trends associated with injection sequence.  
SPR analysis and evaluation 
SPR sensorgrams were analyzed with the aid of Scrubber 2 and ClampXP software 
(Center for Biomolecular Interactions Analysis, University of Utah). (29-31)  Reference 
cell responses were subtracted from corresponding active response curves. Double-
referenced curves were acquired by further subtracting the reference cell blank buffer 
injections from each reference-subtracted response curve. (32)  The resulting curves were 
then analyzed and fitted to the kinetic models. Kinetic modeling and simulations were 
performed with ClampXP software with the Langmuir 1:1 model or the heterogeneous 
surface model; globally fitted parameters were determined for each kinetic dataset per Fn 
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fragment. Equilibrium binding constants were calculated from fitted kinetic constants. 
Goodness of fit for each model was determined by evaluating the residual plots and 
residual sum of squares. 
Cell spreading and α3β1 integrin binding 
 In order to determine the role of Fn fragments in epithelial cell spreading, RLE-
6TN cells were cultured on FnIII9‟10 (2 M), FnIII
9R-A
10 (2 M), FnIII9
2G
10 (2 M), 
FnIII9
4G
10 (2 M), Fn (0.1 M), or Ln (0.1 M) coated, hd-BSA blocked coverslips in 
serum-free DMEM/F12 media for 3 hours and fixed with 4% formaldehyde. The 
concentration of Fn was chosen based on previous studies showing similar binding of an 
antibody specific to the 7-10 type III repeats of Fn (clone HFN7.1a1) (13) to Fn coated at 
0.1µM and the Fn fragments at 2 M concentrations. The concentration of Ln was chosen 
based on ELISAs showing saturation of the surface using 0.1 M.  Cells were washed 
with PBS, fixed with 4% formaldehyde, permeabilized with 0.2% Triton-X 100 and then 
blocked with 10% goat serum.  Integrin 3 (Ralph 3.2) antibodies were incubated 
overnight at 4°C then washed thoroughly with PBS + 0.2% Tween-20. Secondary 
antibodies (Alexa-Fluor-488 goat-anti-mouse, Invitrogen; FITC-conjugated goat anti-
Armenian hamster, Santa-Cruz Biotech) were incubated for 1 hour then washed 
thoroughly with PBS + 0.2% Tween-20.  Actin was stained with Texas-red phalloidin 
(Invitrogen) and nuclei were stained with Hoescht stain (Invitrogen).  Coverslips were 
mounted and images acquired with a Nikon Eclipse (TiE) inverted fluorescence 
microscope at 100X magnification (PlanApo 100X, 1.4 NA oil-immersion objective) 
with a CoolSNAP HQ2 Monochromatic CCD camera.  Representative images are 
presented.  Area and perimeter of individual cells was determined for each condition 
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using Image J (NIH Freeware) image processing software, and circularity was determined 
using the equation circularity = 4π(area/perimeter
2
).   Three independent images were 
analyzed for each condition, and at least 10 cells were analyzed per image.  Data is 
pooled from all 3 images analyzed per condition.  Statistical analysis was performed by 
multi-variate ANOVA using Prism (Graphpad Software Inc., La Jolla, CA, USA). 
Statistical significance was achieved for p<0.05.  
 
Results 
Kinetic binding models 
SPR with soluble recombinant integrin immobilized to the surface of the sensor chip was 
utilized to determine the role of FnIII9 in integrin α3β1 interactions with Fn.  (Figure 
4.1) The experimental data was fit with the use of both a Langmuir 1:1 model and a 
heterogeneous surface model to account for variable conformational state of immobilized 
integrin that can result from amine coupling.   
 
 
Table 4.1: FnIII9’10 variants produced and function 
 
Fragment Sequence 1373-1423 of FnIII9-10 Role 
FnIII9‟10  DRVPHSRNSITLTNLTPGTEYVVSIVALN 
 GREESPPLIGQQSTVSDVRPD 
Leu1408 to Pro; Stabilizes relative 





























Figure 4.1: Integrin α3β1 immobilization:  To analyze integrin binding to FnIII9‟10 
variants, recombinant soluble integrin was immobilized onto a Biacore sensor chip to 
achieve approximately 1500 resonance units.  (A)  Schematic of immobilized integrins on 
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In comparing model simulation results, the heterogeneous ligand model fit the 
experimental binding data better than the Langmuir 1:1 model. Response, simulation 
curves, and residual plots for a single set of experimental data are presented here 
(FnIII9‟10 binding to integrin α3β1; Figure 4.2).  The range for the 1:1 Langmuir model 
(5.85-0.23; Table 4.1) was higher than the heterogeneous ligand model (1.5-0.18; Table 
4.2), suggesting that the fitted heterogeneous ligand model deviated less from the 
experimental data. In addition, graphically plotting the residuals, which are defined as the 
difference between experimental data and fitted curves, over time showed that the 
residuals for 1:1 Langmuir model followed a systematic trend (Figure 4.2C), indicative 
of fitting an inappropriate model to the experimental data.  (33)  In contrast, the residuals 
for the heterogeneous model were lower and more randomly distributed (Figure 4.2D), 
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Figure 4.2: Determination of kinetic binding model:  Experimental SPR sensorgrams 
were fit to both a 1:1 Langmuir binding model (A) and a heterogeneous surface model 
(B). Representative fits of sensorgrams obtained from FnIII9‟10 binding to integrin α3β1 
and resulting residuals (C-D) are shown.  Solid lines indicate experimental SPR response 
curves, and dashed red curves indicate fitted models. 
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Figure 4.3:  FnIII9’10 variant binding to immobilized integrin α3β1: Response 
curves obtained from FnIII9‟10 variants binding to immobilized integrin α3β1 were fit to 
a heterogeneous surface model.  Experimental response curves and resulting fits are 




10 (C), and FnIII
4G
10 (D).  Solid lines 




Fitted α3β1 binding affinity parameters: Langmuir 1:1 model   
 
Response curves obtained from all FnIII9‟10 variants binding to integrin α3β1 were fit to 
both a 1:1 Langmuir binding model and a heterogeneous surface model; experimental 
response curves and heterogeneous surface fits are shown in Figure 4.3.  The fitted 
parameters ka (“on rate”) and kd, (“off rate”), calculated Kd and residual sum of squares 
of the fit of each FnIII9‟10 variant, Fn, and Ln using a Langmuir 1:1 model are displayed 
in Table 4.2.  Comparing kd values obtained from a Langmuir 1:1 model, FnIII9‟10 was 
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.  Increasing 




 type III repeats with either 2 Gly residues or 4 










respectively, indicating that increasing the space between the PHSRN and RGD sites 
disrupts the interactions between FnIII9-10 domains and integrin α3β1.  Furthermore, an 





.  Equilibrium dissociation constants, which take kd and ka values into 
account, were calculated for each analyte.  FnIII9‟10 was found to have the lowest Kd, 
32nM.  Direct disruption in the PHSRN site resulted in a fivefold increase in Kd to 




 type III repeats by either 2 
or 4 Gly residues resulted in a three and 26-fold increase to 97nM and 855nM, 
respectively.  The Kd value for Ln was the lowest for all analytes, 14nM, which was 
expected, as Ln is thought of as the dominant ligand for integrin α3β1; however, Fn was 
found to have a high affinity for the integrin, with a Kd of 24nM.  These results indicate 
that Fn does bind integrin α3β1 with a high affinity, and this binding is dependent on the 
positioning and spatial orientation of the PHSRN and RGD sites. 
 








FnIII9‟10 4.3+/- 0.3 7.1+/- 0.29 32 1.7 
FnIII
9R-A
10 0.49+/- 0.44 59+/- 8.4 172 2.56 
FnIII
2G
10 1.12+/- 1.12 10.8+/- 5.2 97 2.52 
FnIII
4G
10 0.311+/- 0.19 27.5+/- 1.7 855 5.85 
Fn 1.0+/- 0.81 2.5+/- 0.9 24 2.5 
Ln 3.47+/- 1.8 4.87+/- 2.46 14 0.223 
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Fitted α3β1 binding affinity parameters: heterogeneous surface model   
 
Crystal structures of integrins binding to their ligand show that 1 integrin binds to 1 
ligand. Therefore, it was expected that the data would be modeled best by a simple 
Langmuir 1:1 interaction.  However, examination of the residual plots obtained from the 
Langmuir 1:1 fit showed that the residuals followed a systematic trend (Figure 4.2C), 
indicating an inappropriate model for the experimental data.  The observed lack of fitting 
of the Langmuir 1:1 model could be the result of the presence of both high and low 
affinity states of the receptor on the surface.  Integrins inherently can present both high 
and low affinity states, which can result in a heterogeneous surface displaying complex 
binding kinetics.  Furthermore, the amine coupling procedure utilized for immobilization 
of integrin onto the surface can result in a random receptor orientation (Figure 4.1B) and 
heterogeneous surface, also presenting both high and low affinity states of receptor.  In 
order to account for the possibility of both high and low affinity states of the integrin, a 
heterogeneous surface model was utilized to fit the response curves.  As shown in Figure 
4.2, the heterogeneous surface model results in a better fit to the experimental response 
curves than a simple Langmuir 1:1 model, as demonstrated by lower and more randomly 
distributed residual plots (Figure 4.2.D).  The fitted parameters ka1, kd1, ka2, kd2, calculated 
Kd1 and Kd2, and residual sum of squares of the fit of each FnIII9‟10 variant, Fn, and Ln 
using a heterogeneous surface model are displayed in Table 4.3.  As expected, 
examination of the fitted parameters obtained from a heterogeneous surface model 
demonstrates a high affinity binding event and a secondary low affinity binding event.  
The respective contribution of high affinity and low affinity binding to total binding 
using the heterogeneous surface model can be seen graphically in Figure 4.3, which 
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shows simulation sensorgrams generated by the heterogeneous surface model for 
FnIII9‟10 binding to integrin α3β1.  Lower affinity states of the integrin result in a series 
of lower affinity binding events, described collectively by ka2, kd2, and the resulting 
calculated Kd2.   



















FnIII9‟10 211+/- 365 128+/- 194 6.06 31.4+/-34.9  192+/- 32.1 61.0 1.5 
FnIII
9R-A
10 48.2+/- 43.3 757+/-93.9  157 0.63+/- 0.78 125+/- 20.8 1978 2.38 
FnIII
2G
10 69.3+/- 117 596+/- 102 85.9 46.4+/- 79.3 54.3+/- 86.4 11.7 2.50 
FnIII
4G
10 15.1+/- 23.8 748+/- 123 495 180.2+/- 30 45.4+/- 72.7 24.9 4.1 
Fn 1.62+/- 0.6 2.43+/- 0.66 13.1 21.8+/-30.6  1341+/- 178 615 2.0 




Figure 4.4:  Contribution of high affinity and low affinity binding in heterogeneous 
surface model.  Simulation sensorgrams generated by the heterogeneous surface model 
for FnIII9‟10 to integrin α3β1. The combined response, denoted by the black line, is a 
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Evaluation of the fitted parameters for the high affinity binding events demonstrates 
trends similar to those obtained through the Langmuir 1:1 fitting.  Once again, it was 









 type III repeats with 









respectively, indicating increasing the space between the PHSRN and 
RGD sites disrupts the interactions between FnIII9-10 domains and integrin α3β1.  
Furthermore, the disrupting Arg to Ala point mutation within the PHSRN site resulted in 




.  Equilibrium dissociation constants, which takes kd1 and 
ka1 values into account, were calculated for each analyte for the high affinity binding 
state, and FnIII9‟10 was again found to have the lowest Kd1 of all FnIII9'10 variants, with 
a value of 6.06nM.  Direct disruption in the PHSRN site resulted in a 26-fold increase in 




 type III repeats by 
either 2 or 4 Gly residues resulted in a 14- and 82-fold increase to 85.9nM and 495nM, 
respectively.  The Kd value for Ln was the lowest for all analytes, 7.85nM, while Fn was 
also found to have a high affinity for the integrin, with a Kd of 13.1nM.  Focusing on the 
high affinity binding parameters obtained from the heterogeneous surface model shows 
similar trends to those observed through the Langmuir 1:1 model, and demonstrates that 




 type III domains of Fn results in affinities for integrin 
α3β1 similar to those observed for the classical α3β1 ligand Ln.      
FnIII9‟10 binding to integrin α3β1 is dependent on the presence of divalent cations 
 
Integrin binding is typically dependent on the presence of divalent cations, (19, 34) and 
as such all SPR experiments were performed in the presence of 2mM each MgCl2 and 
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MnCl2.  To confirm that integrin binding to FnIII9‟10 variants is dependent on the 
presence of divalent cations, binding events were characterized in the presence of 2 mM 
EDTA.  Experimental response curves for FnIII9‟10 variants in the presence of 2mM 
each MgCl2 and MnCl2 are shown in Figure 4.4A, and experimental response curves in 
the presence of EDTA are shown in Figure 4.4B.  In the presence of EDTA, minimal 
binding to integrin α3β1 was observed, indicating as expected, that FnIII9‟10 binding is 
dependent on the presence of divalent cations. 
 
Figure 4.4:  FnIII9’10 variant binding to integrin α3β1 is dependent on the presence 







10 binding to integrin α3β1 are shown in the absence (A) or presence (B) of 






10 responses in the absence 
of EDTA are shown in black, red, blue, and green lines respectively (A).  The same 
response curves are shown in cyan (B) superimposed with response curves in the 
presence of EDTA shown in blue. 
 
     
 
Kd values for control integrins 
 
The role of the PHSRN site, as well as the relative orientation with respect to the RGD 
site, is critical for α5β1 binding to Fn, while binding to αvβ3 only requires the RGD site.  
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10, Fn, and Ln to immobilized integrin α5β1 and αvβ3 was investigated.  Curves 
were fit to a simple Langmuir 1:1 model.  Experimental curves and calculated Kd values 
are shown in Figure 4.5.  As expected, α5β1 binding was found to depend on the 
presence and spatial orientation of the PHSRN site.  Equilibrium dissociation constants 
were calculated for each analyte, and FnIII9‟10 was found to have the lowest Kd of all 







found to have Kd values of 3100 nM, 417 nM, and 2530 nM, respectively.  Fn and Ln 
were found to have Kd values of 44 nM and 519 nM, respectively.  Though Ln is not 
typically regarded as a ligand for α5β1, there have been previous reports demonstrating 
interactions between these molecules.  (35)  Analysis of binding parameters using the 
heterogeneous surface model demonstrates that these interactions are largely due to the 
secondary binding events.   
Evaluation of FnIII9‟10 binding to integrin αvβ3 was not dependent on the presence or 
spatial orientation of the PHSRN site, which was expected as αvβ3 interactions occur 
through the RGD site alone.  Equilibrium dissociation constants were calculated for each 







10 were found to have Kd values of 59.6 nM, 25.9 
nM, 44.5 nM, and 21.5nM, respectively.  Though all values were comparable, minor 
differences in binding were observed, and, interestingly, an opposite trend from α5β1 







10.  Fn was found to have a Kd value of 9.59 nM, while only minimal binding 
was observed to Ln. 








Figure 4.6:  FnIII9’10 variants bind to control integrins α5β1 and αvβ3 as 
previously described.  Kd values for FnIII9‟10 variants, Fn, and Ln interactions with 







Epithelial cell spreading on FnIII9‟10 variants 
 
To characterize α3β1 binding to FnIII9‟10 variants in a cell system and subsequent 
changes in cell spreading, RLE-6TN cells, an alveolar epithelial cell line, were cultured 
on Fn fragments, Fn, and Ln for a period of 3 hours and then stained for integrin subunits 
3 and actin.  This cell type highly expresses α3β1 and also expresses α5β1 and several 
αv integrins.  Cells cultured on Ln and FnIII9‟10 displayed staining for 3, while cells 
cultured on Fn and all other FnIII9‟10 variants displayed minimal staining for 3 
integrins (Figure 4.6).  Cells cultured on FnIII9‟10 displayed a rounded, cuboidal 
morphology and diffuse staining for actin, which was similar to cellular responses on Ln.  
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Cells cultured on Fn and all other FnIII9‟10 variants displayed were more spread and 
began to display aligned actin filaments.  Cell shape was further characterized through 
analysis of circularity, with values closer to 1 indicating a more rounded cell.  Cells 
cultured on FnIII9‟10 exhibited a circularity value of 0.79, which was similar to cells 
cultured on Ln, with a circularity value of 0.73.  Cells cultured on Fn and all other 
FnIII9‟10 variants were found to have significantly lower circularity values compared to 





Figure 4.7:  Cell spreading on Fn mutants.  To evaluate cell-surface α3β1 integrin 
binding to FnIII9‟10 variants and control surfaces and cell spreading responses, RLE-






10, Fn, or Ln 
coated surfaces for 3 hours.  α3β1 integrin binding was visualized through 
immunofluorescence staining (green), and actin (red) was visualized through staining 
with Texas-red-X conjugated phallodin.  Circularity was calculated to measure 
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Discussion 
These studies show that Fn binds integrin α3β1 in cell-free system, and this 
binding is dependent on the presence of the PHSRN site and is dependent on the spacing 
relative to the RGD site.  The results from this study provide significant insights into the 
role of changes in Fn conformation, such as those resulting from molecular unfolding, in 




 type III 
repeats, and what is classically considered a Ln receptor, integrin α3β1.  These findings 
have implications in dynamic epithelial tissue wound healing responses since integrin 
α3β1 is highly expressed by many epithelial cells, which interact with Fn predominantly 
during wound healing.  
  The role of the PHSRN sites in α5β1 integrin binding to Fn is well characterized, 
and in addition, this site has been shown to enhance binding of additional integrins, as 
illustrated by its role in facilitating strong interactions between Fn and the platelet 
integrin αIIbβ3. (36)  Studies suggest that the PHSRN site acts to stabilize the high 
affinity conformation of the RGD site required for α5β1 integrin binding.  The results 
presented in this aim show that α3β1 integrin binding to Fn is also dependent on the 
relative positioning of the RGD and PHSRN sites.  Previous investigations to elucidate 
potential ligands for integrin α3β1 have been conflicting regarding interactions with Fn.  
Many of these studies involve cell based attachment assays, which are at times difficult to 
interpret, especially in the case of integrin α3β1, in which binding affinity to ECM 
ligands is influenced by the presence of additional integrins. (37)  Studies utilizing 
soluble integrins in cell free systems are also conflicting.  For example, studies by Eble et 
al. showed minimal α3β1 binding to Fn. (18)  Interestingly, these studies showing 
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minimal binding were performed on tissue culture plastic, while several studies 
confirming Fn/α3β1 interactions utilized ECM affinity columns. (19, 38)  Furthermore, 
the studies presented here exploring ATII cell binding to full length Fn show minimal 
staining for α3β1.  The findings of this aim possibly bridge these discrepancies.  Fn has 
been shown to undergo unfolding upon adsorption as a consequence of the hydrophobic 
effect and the protein adopting its lowest energy state. (39-42)  Such unfolding events 
likely disrupt the relative positioning of the RGD and PHSRN sites, and according to the 
SPR studies presented here, would disrupt α3β1 binding.  This conclusion is further 
supported by the fact that full length Fn in solution binds 3 1 exceptionally well, as 
indicated by the presented SPR results. 
Because 3 1 and 5 1 integrin are involved in epithelial wound repair, these 
findings that 3 1 integrin, like 5 1 integrin, binds to Fn in a synergy dependent 
manner have implications in cell interactions during wound healing.  Alveolar epithelial 
type II cells (ATII) only express 5 1 integrin in response to injury; (43) therefore, it is 
likely that integrin 3 1 binds Fn with great affinity in this cell type in early wound 
repair before 5 1 integrin is highly expressed.  Though 5 1 appears to be the main Fn 
receptor during alveolar wound repair, integrin blocking experiments with airway 
epithelial cells showed that in addition to 5, 1, and Fn blocking antibodies, 3 
blocking antibodies also resulted in a significant decrease in wound repair. (43)  
Interestingly, it has been shown that integrin 3 1 binding to Fn can be affected by the 
presence of 5 1 integrin such that 3 1 binding is low in cells expressing 3 1 and 
5 1 at comparable levels, but 3 1 binding to Fn is greatly enhanced in H69 cells that 
highly express 3 1 compared to other integrins.  (19) These reports, taken along with 
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the findings of this aim, suggest that 3 1 binding to Fn may modulate wound repair by 
facilitating binding to ECM in a wound healing environment as the ECM composition 
transitions from predominantly Ln to high levels of Fn.   
Control SPR experiments demonstrate similar affinities of all FnIII9‟10 variants 
for integrin αvβ3, with all FnIII9‟10 variants showing affinities in the 10s of nM range.  
However, small variations were observed, with a trend of increasing affinity opposite of 







10.  This indicates that increasing the 




 type III repeats or mutations in the PHSRN site 
may make the RGD site more accessible to αvβ3, but more rigorous studies would be 
required to confirm this interpretation.  The RGD and PHSRN sites have previously been 
described as an on/off “switch” for α5β1 binding to Fn.  These findings shown that in the 
context of epithelial cells, destabilizing the PHSRN and RGD sites may turn the switch 
off for α3β1/α5β1 binding and on for αv integrin binding.  Highlighting the significance 
of such an integrin switch, binding of α3β1/α5β1 integrins have markedly different 
effects on epithelial phenotype compared to αv integrin binding.  Integrin α3β1 epithelial 
cell interactions are associated with maintenance of epithelial phenotype and wound 
healing, while interactions with αv integrins have been associated with abhorrent wound 
healing, scar tissue formation, epithelial to mesenchymal transitions, and even tumor 
metastasis.  (17, 24, 26, 44) 
Using SPR, these results show for the first time that integrin α3β1 binds FnIII9‟10 
with high affinity, similar to affinity seen for the classical α3β1 ligand Ln, in a PHSRN-
dependent manner.  Furthermore, the physiological relevance of these interactions are 
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confirmed by demonstrating differences in cell spreading in epithelial cells cultured on 
FnIII9‟10 compared to cells cultured on FnIII9‟10 with mutation in the PHRSN site or 
alterations in the spatial orientation of RGD and PHSRN.  These studies provide insights 
into how Fn interactions can contribute to normal vs. pathological wound healing. 
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CHAPTER 5 
FIBRONECTIN-INDUCED EPITHELIAL TO MESENCHYMAL 




 Epithelial to mesenchymal transition (EMT) is a fundamental hallmark of 
invasive pathologies such as cancer and fibrosis.  EMT is also vital for proper 
development, whereas dysregulation of EMT leads to significant tissue and organ defects.  
As a consequence, a significant amount of effort has been devoted to understanding the 
mechanisms driving these drastic phenotypic shifts. EMT, the phenotypic 
transdifferentiation of cells from epithelial to mesenchymal lineages, is a highly 
orchestrated process involving the integration of biochemical signals from ECM 
receptors (integrins) and growth factor receptors like transforming growth factor-  (TGF-
) receptor and receptor tyrosine kinases. (1) 
The contribution of biochemical components of the ECM in directing cell fate, and in 
particular EMT, is becoming more established through traditional cell biological studies.  
In particular, the ECM-associated growth factor TGF-  is highly implicated in EMT, (2-
10) but only in the context of provisional matrices like fibrin and fibronectin (Fn).  
Epithelial cells cultured on laminin (Ln) substrates selectively undergo apoptosis in the 
presence of active TGF  (4) and these responses appear to be a consequence of integrin 
specific engagement of the ECM. (11)  Furthermore, there are several reports that suggest 
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epithelial cells will spontaneously undergo EMT when cultured on Fn.  Potentially 
adding to the complexity, recent publications suggest that the physical/mechanical 
properties of the ECM, such as matrix stiffness, can in part regulate a host of cellular 
processes and phenotypes, from regulation of stem cell differentiation to malignant 
phenotypes. (12-17)  Specifically, cells are able to sense the underlying mechanical 
properties of the ECM, such as compliance. (18, 19)  In the case of compliance sensing, 
cells engage their actinomyosin contractile machinery in a manner that facilitates cell-
ECM compliance matching.  In other words, a cell may adjust its internal stress through 
contraction to “match” its external environment. (19)  As a consequence of this mechano-
homeostasis between the cell and its ECM, cells in increasingly rigid, or stiff, 
environments display increased activation of contractile signals like Rho and Rho 
associated kinase (ROCK), resulting in multiple and diverse secondary effects.  An 
elegant example of this is shown by Wipff et. al. who demonstrated that fibroblast 
activation of TGF  increases on increasingly rigid substrates, leading to greater 
myofibroblast differentiation on stiff, but not compliant substrates. (20) These data call 
into question what is currently known about EMT.  The vast majority of published 
accounts describing EMT mechanisms in vitro are based on studies performed on tissue 
culture plastic or glass, both of which have stiffness values in the gigapascal (GPa; 10
9
 
Pa) range.  For reference, native tissues rarely exceed 100 kPa (10
5
 Pa). 
Idiopathic pulmonary fibrosis (IPF), the experimental disease model utilized here, is a 
currently untreatable and ultimately fatal condition with 3 and 5 year mortality rates of 
50% and 80%, respectively. (21) IPF is characterized by excessive extracellular matrix 
(ECM) deposition, resulting in interstitial scar tissue and loss of tissue compliance, (22) 
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not unlike the characteristics of tumor stroma. (14)  Very recent mesoscale (10-100s of 
m) characterization of fibrotic tissue from bleomycin treated mouse lungs indicates that 
tissue stiffness is highly variable within the fibrotic lung and that on average the tissue 
stiffness is increased six-fold compared to healthy tissue. (23)  Although the exact 
mechanisms initiating lung fibrosis are poorly understood, recent studies implicate 
alveolar epithelial type II (ATII) cell EMT in the onset and progression of pulmonary 
fibrosis. (3, 4, 8-10)  EMT has been theorized to increase the number of ECM secreting 
mesenchymal cells perpetuating the fibrotic condition and resulting in the observed 
increase in lung stiffness.  In other words, tissue stiffness is presumed to be a 
consequence of EMT.  Despite recent evidence highlighting the effect of matrix stiffness 
on cell phenotype, it is perhaps surprising that it has not been asked whether the converse 
is true: that alterations in tissue stiffness lead to the observed EMT in fibrosis.  If the later 
is true then it has major implications in therapeutic approaches towards EMT-related 
diseases, like cancer and fibrosis.  
In this aim, it was hypothesized that as epithelial cells engage increasingly rigid 
environments/substrates, they will become increasingly contractile leading to enhanced 
TGF  activation and EMT.  In this study the elastic moduli of fibrotic and non-fibrotic 
regions were characterized in an in vivo model of pulmonary fibrosis and subsequently, 
the observed range of matrix/substrate rigidities were utilized to investigate the potential 
for stiffness-mediated EMT events in vitro.  
 
 
 - 103 -   
Materials and Methods 
Animals and bleomycin-induced fibrosis 
8-10 week old C57/Bl6 mice (Charles River, MA) were intubated and 3.2 U/kg 
bleomycin (EMD Chemicals, NJ) was instilled intratracheally in 50 L of sterile saline.  
Mice were sacrificed after 14 days for tissue harvesting.  All experiments were performed 
in accordance with guidelines set forth by the National Institutes of Health and Georgia 
Institute of Technology Institutional Animal Care and Use Committee-approved 
protocols.  
Lung tissue preparation for fluorescence microscopy and AFM force mapping 
Lungs were inflated using 2% ultra low-melting temperature agarose (SeaPrep, Lonza 
Inc.) warmed to 37 C and subsequently allowed to solidify on ice.  The left lobe was 
dissected into approximately 1 cm
3
 blocks, and 100 m thick slices were generated using 
a VT100S vibratome (Leica, IL).  Samples were kept in 10% FBS, 1% penicillin & 
streptomycin-supplemented DMEM after harvesting and during mechanical analysis.  To 
allow for visualization of tissue architecture and type, lung slices were stained with 
fluorescein-labeled lectin from the Cry-Baby Tree, Erythrina crystagalli (ECL; Vector 
Laboratories) to label alveolar type I epithelial cells (ATI) and LysoTracker Red 
(Invitrogen) to label the lamellar bodies of alveolar type II epithelial cells (ATII).  Cell 
nuclei were stained Hoechst 33258 (Invitrogen).  Slices were incubated at 37 C for 30 
minutes before washing with warm DMEM.   
AFM force spectroscopy analysis 
Vital stains for ATI, ATII cells and cell nuclei were used to direct measurements to peri-
alveolar regions of interest.  For fibrotic regions, areas of enhanced cellularity distinct 
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from larger airways were chosen. Using a MFP-3D-BIO AFM (Asylum, ST) with a 4.74 
m diameter silica glass bead customized-silicon nitride AFM tip (Veeco), peri-alveolar 
regions were located and probed by contact mode force spectroscopy at a scan rate of 1.0 
Hz.  Cantilever spring constants were determined using the thermal resonance frequency 
method with values ranging from 0.06-0.08 N/m.  Force-indentation profiles were 
measured in 10x10 um grids with approximately 600 nm spacing between points.  A 
minimum of 8 regions were selected for each tissue slice and a minimum of 3 slices used 
per mouse.  Force-indentation profiles were fit to a Hertz model for elastic deformation 
between spheres to calculate the Young‟s modulus for each point, assuming a Poisson‟s 
ratio of 0.4.  For single cell analysis, single force points were taken from ~5 locations 
about the cell body in regions that were greater than 300 nm in height and not directly 
above the nucleus.  Similarly, regions of the gel substrate surrounding measured cells 
were probed.  At least 10 cells were measured per substrate and averages of cell stiffness 
and gel stiffness for each gel fabrication mixture are presented.   
LIVE/DEAD assay of tissue cell viability 
To study viability of resident tissue cells over the time course of mechanical 
characterization, the LIVE/DEAD Viability Kit for mammalian cells was used (L-3224, 
Invitrogen). Lung slices were incubated with 10 M calcein AM and 5 M EthD-1 for 1 
hour prior to their corresponding time point. Samples were then fixed with 4% 
formaldehyde and mounted.  Additionally, a dead control group was included by 
incubating samples with 70% methanol for 30 minutes prior to dye incubation. Samples 
were imaged with a laser scanning confocal microscope (LSM 510 META, Carl Zeiss 
Inc.) at 63x.   
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Poly-acrylamide gel production 
To determine the role of substrate stiffness on EMT events, poly-acrylamide (PA) gels of 
varying bisacrylamide concentrations were created on amino-silanated coverslips as 
previously described.(24)  PA gel solutions were produced by combining acrylamide and 
bisacrylamide to final concentrations of 8% acrylamide (Biorad, Hercules, CA, USA) and 
0.048%, 0.117%, 0.208%, 0.296%, or 0.391% bis (Biorad) to obtain gels with final 
elastic moduli of 2 kPa, 8 kPa, 16 kPa, 24 kPa, or 32 kPa respectively. 50 µl of each 
solution was polymerized by the addition of ammonium persulfate (VWR, West Chester, 
PA, USA) and N,N,N‟,N‟-tetramethylethylenediamine (Biorad, Hercules, CA, USA) (1% 
and 0.1%  final concentration respectively).  The gels were allowed to polymerize for 
approximately 20 minutes, then washed extensively with PBS. Human plasma fibronectin 
(Fn) (BD Bioscience, San Jose, California, USA) was covalently attached to the surface 
using the heterobifunctional crosslinker sulfosuccinimidyl-6-(4‟-azido-2‟ nitrophenyl-
amino)hexanoate (sulfo-SANPAH; Pierce Chemical Co., Rockford, IL., USA).  
Following an overnight incubation with 20 µg/ml Fn, gels were then washed with PBS.  
To confirm equivalent amounts of Fn were cross-linked to each surface regardless of 
stiffness, gels were incubated with 5% Alexa-488 Fn/ 95% unlabeled Fn.  Fluorescence 
was quantified using a plate reader and normalized to gels with no cross-linked Fn.  No 
statistical difference in fluorescence was observed between gels (Appendix A.1). 
Cell culture 
RLE-6TN cells, an alveolar epithelial cell line were purchased from ATCC, and grown in 
DMEM/F12 media supplemented with 10% FBS, 1% P/S.  To determine the effect of 
substrate stiffness on epithelial cell fate, cells were plated on PA gels with Fn cross-
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linked on the surface with the following rigidities:  E=2 kPA, 8 kPa, 16 kPA, 24 kPA, 32 
kPA, or on glass coverslips coated with Fn or Ln as controls.  Cells were plated in growth 
media in the absence or presence of 10 µM Y-27632 (EMD Biosciences, Gibbstown, NJ, 
USA).  To determine the role of TGF  in substrate mediated EMT, cells were cultured on 
the lowest stiffness substrate (2kPa) in the absence or presence of 5 ng/mL active TGF  
(R&D Systems, Minneapolis, MN, USA) and cells cultured on the highest stiffness 
substrate (32 kPa) were cultured in the absence or presence of 10 ug/mL TGF  
neutralizing antibody (9016, R&D Systems).   Media was changed every 48 hours. 
Immunofluorescence staining and circularity analysis 
Following culture for 5 days, cells were washed with PBS, fixed with 4% formaldehyde, 
permeabilized with 0.2% Triton-X 100 and then blocked with 10% goat serum.  Primary 
anti- -SMA (1A4, Sigma-Aldrich) or anti-E-cadherin (36/E-cadherin, BD Transduction 
Laboratories) antibodies were incubated overnight then washed thoroughly with PBS + 
1.5% goat serum.  Alexa-Fluor-488-conjugated goat-anti-mouse (Invitrogen) was used as 
the secondary antibody. To characterize cell shape, actin was stained with Texas-red 
phalloidin (Invitrogen) and nuclei were stained with Hoescht stain (Invitrogen). Images 
were acquired with a Nikon Eclipse (TiE) inverted fluorescence microscope at 20X 
magnification (PlanFluor 20X, 0.5 NA objective) with a CoolSNAP HQ2 
Monochromatic CCD camera.  Experiments were performed in triplicate, and images 
presented are representative from 5-10 random fields for each independent experiment.  
To characterize circularity, area and perimeter of individual cells stained for actin were 
determined for each condition using Image J (NIH Freeware) image processing software, 
then circularity was determined using the equation circularity = 4π(area/perimeter
2
).   
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Three independent images were analyzed for each condition, and at least 10 cells were 
analyzed per image.  Data is pooled from all 3 images analyzed per condition.  
Immunoblot 
RLE-6TN cells were cultured for 5 days then washed with PBS and cells lysed directly in 
Lamelli buffer containing protease and phosotase inhibitors (Roche Applied Sciences).  
Total protein concentration was determined using the BCA protein quantification kit 
(Pierce Chemical Co.).  40 ug of total protein was separated electrophoretically on a 4-
15% gel, then transferred to a nitrocellulose membrane using a semi-dry transfer system, 
blocked with 5% nonfat dry milk in TBS, then incubated with E-cadherin (36/E-
cadherin), pan cytokeratin (5D3 + LP34, abcam, Cambridge, MA, USA), α-SMA (1A4), 
prolyl-4-hydroxylase (P4H; 1D3, Santa Cruz Biotechnology, Santa Cruz, CA, USA), or 
GAPDH (14C10, Cell Signaling Technologies, Boston, MA, USA) antibodies overnight 
at 4° C.  Following washing with TBS + 0.1% Tween 20, membranes were incubated for 
2 hours with IR secondary antibody (Licor), washed, and then imaged using the Odyssey 
IR scanner.  Western blots were quantified using Image J image processing software, 
using GAPDH as the endogenous control.       
Analysis of pai-1 mRNA expression   
Cells were trypsinized, mRNA isolated (RNAeasy Mini Kit, Qiagen, Valencia, CA, 
USA) and c-DNA generated (High Capacity cDNA Reverse Transcription Kit, Applied 
Biosystems, Foster City, CA, USA).  Primers (Invitrogen, Carlsbad, CA, USA) used for 
q-PCR reactions were as follows: -actin forward ACCCGCCACCAGTTCGCCAT; -
actin reverse CTTGCTCTGGGCCTCGTCGC; Plasminogen activator inhibitor-1 (Pai-1) 
forward CACAGTGCTGGGTGTAATGG; Pai-1 reverse 
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GTTTGTGGGGCAGCTATTGT (designed using Primer3Plus software). Q-PCR was 
performed on a Step One Plus ABI thermocycler (Applied Biosystems) using Power 
SYBR Green Master Mix (Applied Biosystems).  Data was analyzed using the Ct 
method taking reaction efficiency into account (25) using -actin as the endogenous 
control and comparing expression levels to cells cultured on the lowest stiffness substrate 
(E=2 kPA).  Q-PCR reactions were run in triplicate and performed for 3 independent 
experiments.  Data shown was pooled from 3 independent experiments. 
Statistical Analysis: All statistical analysis for 3 or more experimental groups was 
performed by multi-variate ANOVA using Prism (Graphpad Software Inc., La Jolla, CA, 




Epithelial cells experience significantly greater stiffness in fibrotic versus normal lung. 
Given that one of the hallmarks of fibrotic diseases is an increase in tissue 
stiffness, the mechanical environment of the alveolus in normal and pathological 
conditions was characterized to determine the range of stiffness encountered by ATII 
epithelial cells in vivo.  Bleomycin-treated mice were utilized to model pulmonary 
fibrosis, and as previously demonstrated, fixed lung sections isolated from the fibrotic 
lung displayed increased cellularity and alveolar wall expansion as observed through 
H&E staining compared to non-treated mice (Figure 5.1A).  Because it has been shown 
that cells contribute significantly to the mechanical properties of tissues, and in addition 
fixing tissue can alter tissue mechanics, living lung slices were utilized for AFM analysis 
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of tissue elasticity.  Lung tissue from either normal or bleomycin-treated mice was tested 
within 6 hours of harvest to ensure tissue integrity and resident cell viability.  Lung 
architecture observed in fixed tissue is recapitulated in thick (~100 m) living lung slices 
as observed by widefield fluorescence microscopy using vital stains for ATI and ATII 
cells, and cell nuclei (Figure 5.1B).  The average Young‟s modulus of lung tissue was 
characterized through AFM analysis. To ensure correct spatial and anatomical location 
within the lung, peri-alveolar regions were located based on vital staining for ATI and 
ATII epithelial cells; representative DIC-fluorescence overlay, fluorescence-only image, 
and a force-indentation profile are depicted (Figure 5.1C-E).  Mean and standard 
deviation values are reported for samples obtained from individual mice (Figure 5.1F) 
and as mean values of all samples (Figure 5.1G). The average Young‟s modulus of 
normal lung tissue was 1.96 kPa (+/- 1.21), and in the bleomycin treated mouse, the 
average Young‟s modulus increased to 17.25 kPa (+/- 11.06).  This is in good agreement 
with previously published work exploring the micro-scale bulk tissue mechanics of 
lung.(23) Cell viability within prepared tissue slices was verified using calcein AM and 
EthD-1.  Predominately viable cells/tissue were detected as long as 24 hours post harvest 
(Figure 5.1H, I). 
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Figure 5.1:  Alveolar epithelial cells undergo EMT when cultured on substrates of 
increasing stiffness Lung slices from mice exposed to bleomycin display higher 
Young’s modulus than those obtained from healthy mice.  The in vivo mechanical 
environment of the alveolus was investigated at cellular length scales to determine the 
range of stiffness encountered by ATII cells under normal and pathologic conditions.  
H&E staining was performed on normal and treated lung sections (A) and thick living 
lung slices were imaged with widefield fluorescence using vital stains for ATI, ATII 
cells, and cell nuclei (B). The average Young‟s modulus of lung tissue was characterized 
through AFM analysis, with a representative DIC-fluorescence overlay (C), fluorescence-
only image (D), and force-indentation profile for the depicted region shown (E).  Mean 
and standard deviation values are reported for samples obtained from individual mice (F) 
and as mean values of all samples (G).  The time course of cell viability within tissue 
slices was assayed using calcein AM and EthD-1, and mostly viable cells were detected 
after 24 hours post harvest (H, I). 
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Alveolar epithelial cells undergo EMT when cultured on substrates of increasing stiffness  
EMT has previously been observed in vivo in fibrotic lung regions of both human 
IPF patients and bleomycin-treated mice.(4)  Because a range of stiffness was observed in 
vivo in fibrotic lung regions, it was interrogated if increases in matrix/substrate stiffness 
alone would be sufficient to induce EMT.  Utilizing polyacrylamide (PA) gels with 
surface immobilized Fn and varying stiffness from 2 kPa to 32 kPa, epithelial cells were 
cultured for 5 days and then analyzed for EMT events.  EMT was characterized through 
analysis of expression of various epithelial and mesechymal markers by 
immunofluorescence staining and western blotting.  Cells cultured on 2 kPa and 8 kPa 
surfaces maintained an epithelial phenotype with positive staining for E-cadherin at cell-
cell contacts and minimal staining for -SMA, while cells cultured on 16 kPa-32 kPa 
surfaces exhibited increasing EMT with minimal staining for E-cadherin at cell-cell 
contacts and positive staining for -SMA (Figure 5.2A-N).  The shift from epithelial to 
mesenchymal phenotypes as stiffness increased was further verified with western blots 
for E-cadherin and cytokeratin (epithelial) and -SMA and prolyl-4 hydroxylase (P4H; 
mesenchymal, Figure 5.2O). Western blots were quantified and expressed as fold change 
compared to expression on 2 kPa, normalizing to GAPDH expression (Figure 5.2P). 
Higher expression of cytokeratin was observed on 2 kPa and 8 kPa substrates compared 
to the higher stiffness substrates, while expression of -SMA and P4H was higher on 
16kPa-32kPa substrates than on the lower stiffness substrates.  While E-cadherin was lost 
from cell-cell contacts as stiffness increased, total protein expression was similar in cells 
on all surfaces, although there was a slight decrease in expression as stiffness increased.  
These observations are in agreement with reports describing the loss of E-cadherin at 
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cell-cell contacts at early time points during EMT while maintaining intracellular 
localization of E-cadherin.  Loss of E-cadherin expression during EMT often requires up 
to two weeks.(1, 26, 27) ATII epithelial cells have previously been shown to undergo 
EMT on Fn-coated glass surfaces (~ 30 GPa stiffness) but maintain epithelial phenotypes 
on Ln-coated glass.(4)  Using these conditions as control experiments it was observed, as 
expected, EMT of cells on Fn-coated glass as indicated by significantly increased 
expression of -SMA and P4H and a concomitant decrease in expression cytokeratin and 
a loss of E-cadherin at cell-cell contacts.  Conversely, cells cultured on Ln-coated glass 
surfaces maintained their epithelial nature exhibiting high levels of cytokeratin 
expression, low levels of -SMA and P4H, and maintaining E-cadherin containing cell-
cell contacts.  These results indicate that both the biochemical and mechanical 
microenvironment of the ECM are important contributing factors in driving EMT.    
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Figure 5.2:  Analysis of epithelial and mesenchymal gene and protein expression of 
RLE-6TN cells cultured on substrates of varying stiffness.  RLE-6TN cells were 
cultured on substrates of varying rigidities for 5 days then analyzed for epithelial and 
mesenchymal protein expression through immunofluorescence staining for E-cadherin 
(A-G) and -SMA (H-N) and western blotting for E-cadherin, cytokeratin (epithelial), -
SMA, P4H (mesenchymal), and GAPDH (endogenous control) (O).  Western blots were 
quantified and expressed as fold changed compared to expression on the lowest stiffness 
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Epithelial cells display increasing cytoskeleton alignment, spreading, and cellular 
stiffness in proportion to substrate stiffness. 
EMT is primarily characterized by decreases in epithelial markers and 
concomitant increases in mesenchymal markers, but is also accompanied by changes in 
cellular morphology, including increased cell spreading and cytoskeleton alignment.  
Therefore, stiffness-mediated EMT was further characterized through analysis of cell 
spreading and cytoskeletal organization/stress fiber formation.  Alveolar epithelial cells 
were cultured on substrates of varying stiffness for 5 days, and then stained with Texas-
red-X conjugated phalloidin to visualize the actin cytoskeleton (Figure 5.3A-G).  
Providing further evidence of the role of stiffness in driving EMT, cells cultured on lower 
stiffness substrates (E=2 kPa and 8 kPa) displayed the typical epithelial rounded 
morphology and diffuse cortical staining for actin, while cells cultured on higher stiffness 
substrates (E=16 kPA-32 kPA, and Fn-coated glass) became elongated and increasingly 
displayed aligned, thick actin filaments characteristic of stress fibers.  Recapitulating the 
importance of the biochemical composition of the ECM in EMT, cells cultured on Ln-
coated glass surfaces maintained a round epithelial morphology despite being cultured on 
non-physiologically relevant rigid substrates.  Cell circularity was calculated to quantify 
differences observed in cell shape (Figure 5.3H); values closer to 1 indicate a more 
rounded cell.  Cells exhibited statistically significant decreasing circularity values, and 
were therefore becoming more elongated, with increasing stiffness (p<0.001 each group 
compared to E=2 kPA) with cells exhibiting the following circularity values:  E=2 kPA, 
0.70; E=8 kPA, 0.62; E=16 kPA, 0.46; E=24 kPA, 0.44; E=32 kPA, 0.41; glass-Fn, 0.42; 
glass-Ln, 0.65.  
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It has previously been demonstrated that fibroblasts respond to a range of substrate 
stiffness by increasing their internal stiffness, up to a saturating level of approximately 8 
kPa.(28) It is thought that cellular stiffness matching is the product of cytoskeleton 
rearrangements and activation of Rho-mediated contractility, therefore, based on the 
observations of cytoskeleton rearrangements in response to substrate stiffness, it was 
investigated whether epithelial cell stiffness also increases similarly with substrate 
stiffness. Using similar AFM methodology as with the lung slices, the average Young‟s 
modulus of individual cells and that of their underlying substrate were measured from 
force-indentation profiles (Figure 5.3I).  The average epithelial cell stiffness increased as 
substrate stiffness increased, reaching a maximum at approximately 6 kPa on the stiffest 
gel and Fn-coated glass.  Interestingly, cells on Ln-coated glass exhibited values similar 
to cells on the softest (2 kPa) substrate, with average Young‟s moduli around 0.5 kPa, 
suggesting that increases in cellular stiffness in response to substrate stiffness depend on 
the biochemical context.  To determine the role of cell contractility in cellular stiffness-
matching, the elasticity of cells on Fn-coated glass with the addition of 10 µM of the 
ROCK inhibitor Y-27632 was measured, and it was found that cell stiffness was 
decreased and exhibited values similar to cells on the softest (2 kPa) substrate and Ln-
coated glass substrates.     
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Figure 5.3: Substrate stiffness influences cell shape and actin cytoskeleton 
alignment, which corresponds to increases in single cell stiffness measurements.  
RLE-6TN cells were cultured for 5 days on substrates of increasing stiffness and then cell 
shape and stress fiber formation was analyzed.  The actin cytoskeleton was visualized by 
staining with Texas-red phalloidin and the nuclei stained with Hoescht.  (A-G)  Cell 
circularity was calculated to quantify differences observed in cell shape (H); values 
closer to 1 indicate a more rounded cell. Fluorescent images were acquired with a Nikon 
Eclipse (TiE) inverted fluorescence microscope at 20X magnification. *** denotes 
p<0.001.  Single cell elasticity was measured via AFM force mapping to characterize cell 
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Stiffness-mediated EMT is dependent on cell contractility 
Based on the observation that cellular stiffness increased with increasing stiffness 
and that cellular stiffness on Fn-coated glass could be decreased to levels observed for 
cells cultured on 2 kPa substrate by inhibiting cellular contractility, it was investigated if 
stiffness-mediated EMT was also dependent on contractility.  Cells were cultured for 5 
days on substrates of varying stiffness in the presence of Y-27632 and then EMT events 
characterized as previously described.  In the presence of the ROCK inhibitor, cells 
maintained a round, epithelial morphology and displayed diffuse staining for actin 
regardless of the underlying substrate (Figure 5.4A-G).  Furthermore, cells displayed 
positive staining for E-cadherin at cell-cell contacts (Figure 5.4H-N), minimal staining 
for -SMA (Figure 5.4O-U), maintained equivalent protein expression levels of E-
cadherin, cytokeratin, -SMA, and P4H (Figure 5.4V-W), and remained circular in 
nature (Figure 5.4X), all of which were comparable to those observed on the lower 
stiffness substrates in the absence of ROCK inhibition. In other words, inhibition of cell 
contractility is sufficient to inhibit stiffness-mediated EMT.  These results suggest that 
stiffness-mediated EMT is linked to changes in the cytoskeleton and increased cell 
contractility on increasingly rigid substrates. 
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Figure 5.4: Substrate stiffness-mediated EMT is dependent on cell contractility.  
RLE-6TN cells were cultured on substrates of varying rigidities in the presence of 10 µM 
Y-27632 ROCK inhibitor for 5 days and then EMT responses were analyzed through 
changes in actin cytoskeleton alignment and cell circularity (A-G, X), and changes in 
epithelial and mesenchymal protein expression through immunofluorescence staining for 
E-cadherin (H-N) and -SMA (O-U) and western blotting for E-cadherin, cytokeratin 
(epithelial), -SMA, P4H (mesenchymal), and GAPDH (endogenous control) (V). 
Western blots were quantified and expressed as fold changed compared to expression on 
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Epithelial cells display enhanced TGF  activity when cultured on substrates of increasing 
stiffness.  
 It has been shown in the context of mesenchymal cells that fibroblasts increasingly 
activate latent TGF  as substrate stiffness increases, through a process requiring high 
levels of cell contractile forces.  Because TGF  has been identified as one of the primary 
inducers of EMT and because inhibition of stiffness-mediated EMT was observed 
through inhibition of cell contractility, it was hypothesized that stiffness-mediated EMT 
could also be driven by a similar mechanism in epithelial cells.   To determine if 
differences in substrate stiffness induced changes in TGF  activation in epithelial cells, 
expression of Pai-1, a TGF -specific responsive gene, was analyzed by q-PCR (Figure 
5.5).  Cells displayed increased Pai-1 expression as substrate stiffness increased, with 
cells expressing significantly higher levels of Pai-1 when cultured on the highest stiffness 
substrate E= 32 kPa than cells cultured on substrates of stiffness E=2 kPa, 8 kPA, or 16 
kPa (p<0.01) (Figure 5.5A), indicating that epithelial cells increasingly synthesize and/or 
activate TGF  with increasing substrate stiffness.  A slight twofold increase in TGFβ 
mRNA expression was observed on the highest stiffness substrates (32 kPa and Fn coated 
glass) compared to cells cultured on the lowest stiffness substrate (Figure 5.6).  
Alternatively, cells may display increased TGF  signaling (i.e. sensitivity) in response to 
increasingly rigid substrates. The addition of Y-27632 abrogated this effect and no 
statistical significance was seen between groups cultured in the presence of the inhibitor 
(Figure 5.5B), indicating that TGF  production, activation, and/or signaling and 
subsequent EMT, is dependent on cell contractility.  As expected, control groups cultured 
on Fn-coated glass expressed significantly higher levels of Pai-1 than those cultured on 
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Ln-coated glass (p<0.01) and the addition of Y-27632 abrogated these differences 
(Figure 5.5C).  Furthermore, no significant differences in Pai-1 mRNA were observed 
between cells cultured on Fn-coated glass in media only compared to media plus active 
TGF  and Y-27632, indicating that the inhibition of ROCK does not inhibit normal 
TGF  signaling, thus implicating TGF  activation as the critical step.  In addition, it was 
found that increased TGF  activation on higher stiffness substrates (E=32 kPa) is not 
specific to ROCK signaling but rather more broadly on cell contractility.  Pai-1 
expression was found to significantly decrease in the presence of a variety of cell 
contractility inhibitors (Figure 5.7).  
 
 
Figure 5.5: TGF  activation increases with increases in substrate stiffness as 
determined through Pai-1 mRNA expression:  RLE-6TN cells were cultured for 5 days 
on substrates of varying rigidities in the absence (A) or presence of 10 M Y-27632 (B). 
Levels of expression of the TGF  responsive gene Pai-1 were determined by q-PCR.  
Fold changes in gene expression were determined by CT analysis using β-actin as the 
endogenous control and comparing expression to cells cultured on E=2 kPa in the 
absence or presence of ROCK inhibitor respectively.  Controls included cells cultured on 
glass-Fn or glass-Ln in the absence or presence of Y-27632 (C).  Reactions were 
performed in triplicate.  ** denotes p <0.01 
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Figure 5.6: TGFβ mRNA expression on substrates of varying stiffness.  RLE-6TN 
cells were cultured for 5 days on substrates of varying rigidities in the absence (A) or 
presence of 10 M Y-27632 (B). Levels of expression of TGF  mRNA were determined 
by q-PCR.  Fold changes in gene expression were determined by CT analysis using β-
actin as the endogenous control and comparing expression to cells cultured on E=2 kPa in 
the absence or presence of ROCK inhibitor respectively. Reactions were performed in 





Figure 5.7: Pai-1 mRNA expression on high stiffness substrates is inhibited by a 
variety of cell contractility inhibitors.  RLE-6TN cells were cultured for 48 hours on 
the highest stiffness substrate (E=32 kPA) in the presence of 10 ug/ml TGF  neutralizing 
antibodies, 10 µM HA 1077, 50 µM Blebbistatin, 100 nM cytochaslin D, or media only 
and Pai-1 expression was analyzed.  Pai-1 expression was significantly lower in the 
presence of all contractility inhibitors analyzed compared to cells cultured on 32 kPa 
surfaces in media alone (p<0.01). 
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Stiffness-mediated EMT is driven by TGF  activation and subsequent signaling 
To further confirm that stiffness-mediated EMT is due to TGF  activation and not 
alterations in TGF  signaling, EMT events were analyzed in the presence of active TGF  
on the lowest stiffness substrate (E=2 kPa) and in the presence of TGF  neutralizing 
antibodies on the highest stiffness substrate (E=32 kPa, Figure 5.8).  In the presence of 
active TGF , cells cultured on 2 kPa underwent EMT as evidenced by an elongated 
morphology, stress fiber formation, loss of E-cadherin at cell-cell contacts and positive 
staining for -SMA (Figure 5.8A-B, E-F).  Furthermore, western blot analysis 
demonstrated minimal expression of E-cadherin and cytokeratin, while expression of -
SMA and P4H increased compared to cells cultured on 2 kPa in the absence of 
exogenously added active TGF  (Figure 5.8I, K).   These EMT events were 
accompanied by a significant increase in Pai-1 expression (p<0.05), indicative of active 
TGF  signaling (Figure 5.8M).  The converse was observed on 32 kPa substrates in the 
presence of TGF  neutralizing antibodies.  Cells maintained a round, epithelial 
morphology accompanied by E-cadherin at cell-cell contacts and negative staining for -
SMA (Figure 5.8C-D, G-H).  Western blot analysis demonstrated minimal expression of 
-SMA and P4H, while expression of E-cadherin and cytokeratin as well as Pai-1 mRNA 
level were comparable to cells cultured on 2 kPa surfaces in media only (Figure 5.8J, L, 
N). These results demonstrate that EMT can occur on soft substrates in the presence of 
active TGF , indicating that cells on soft substrates are not less sensitive to TGF  than 
those cultured on rigid substrates.  Furthermore, these data, taken together with the results 
that inhibition of TGF  signaling on rigid substrates inhibits EMT, further supports the 
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hypothesis that stiffness mediated EMT is a consequence of increased cell contractility 
leading to increased TGF  activation.  
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Figure 5.8: EMT events can be induced on low stiffness substrates in the presence of 
active TGF  and inhibited on high stiffness substrates in the presence of TGFβ 
neutralizing antibodies.  RLE-6TN cells were cultured for 5 days on the lowest stiffness 
substrate (E=2 kPA) in the presence of 5 ng/ml active TGF  (A-B, E-F, I, K, M) or on 
the highest stiffness substrate (E=32 kPA) in the presence of 10 µg/ml TGF  neutralizing 
antibodies (C-D, G-H, J, L, N).   EMT events were analyzed though changes in actin 
cytoskeleton alignment and cell circularity (A-D), and changes in epithelial and 
mesenchymal protein expression through immunofluorescence staining for E-cadherin 
(E; G) and -SMA (F; H) and western blotting for E-cadherin, cytokeratin (epithelial), 
-SMA, P4H (mesenchymal), and GAPDH (endogenous control) (K-L).   Western blots 
were quantified comparing expression to cells cultured on substrates in media only (E=2 
kPa, I; E=32 kPa, J).   Levels of mRNA expression of the TGF  responsive gene Pai-1 
were also determined by q-PCR, comparing expression to cells cultured on E=2 kPa  (M) 
or E=32 kPa (N), respectively.   
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Discussion 
EMT is a critical process in the progression of invasive pathologies like cancer 
and fibrosis and as such it is essential that the process is fully understood in order to gain 
therapeutic insights.  This work provides evidence that the micromechanical environment 
with which epithelial cells interact is a strong driving force for EMT.  The stiffer the 
matrix/substrate is, the stronger the pressure to undergo EMT and vice versa.  This 
unique finding raises questions about what is currently known about EMT.  Specifically, 
the vast majority of in vitro EMT research to date has been performed on substrates with 
non-physiological stiffness (i.e. GPa stiffness). (1, 4, 8, 29, 30) 
While stiffness of the cellular microenvironment clearly plays a significant role in 
defining the resident cell phenotype, (13, 14, 20, 23) the origins of the increased tissue 
stiffness are still poorly understood.  It is likely that stiffness emanates from the 
residential cell population and the over-production or activation of cross-linking 
enzymes.  Fibroblasts that have differentiated down a contractile, myofibroblastic 
pathway are known to exhibit significant contractile force. (20)  Such cell-derived forces 
are capable of stressing the surrounding ECM leading to increased microenvironmental 
stiffness.  Additionally, recent evidence suggests that even normal fibroblast 
subpopulations, as in the case of Thy-1 surface expression, may display significant 
differences in their capacity to exert force on their matrix. (31, 32)  Several investigations 
have shown that lysyl oxidase in the tumor microenvironment is sufficient to crosslink 
and stiffen the tumor stroma (33) and transglutaminases have long been known to 
catalyze ECM crosslinking and recently have been shown to result in tissue stiffening. 
(34)  As mentioned previously, the prevailing thought is that EMT precedes tissue 
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stiffening, yet several reports indicate that tissue stiffening occurs prior to the onset of 
fibrosis. 
The data here indicate that tissue/substrate stiffness is necessary but not sufficient to 
induce spontaneous EMT.  The effect of stiffness in the context of EMT depends on the 
ECM ligand.  Increased stiffness acts synergistically with Fn to promote EMT through 
contraction-mediated TGF  activation whereas Ln substrates inhibit the effect of stiffness 
(Figure 5.9).  These data corroborate previous findings on tissue culture plastic/glass 
regarding the role of ECM proteins on EMT (4)  and also support recent evidence that 
integrin-specificity drives mechanotransduction/compliance matching. 
Biochemical signaling through the ECM is clearly dependent on specific integrins 
binding to their extracellular counterpart. (35)  How integrins interact with specific 
extracellular ligands to determine transduction of matrix mechanical properties is less 
understood.  Integrin binding to an ECM ligand can result in physical linkage between 
integrin and the cytoskeleton, allowing force transmission through the attachment site and 
reinforcement of the protein complex. (36, 37)  Recent studies suggest differential 
reinforcement of adhesions based on the dominant integrin being bound. (38, 39)  Rosa-
Cusachs et al. reported dynamic stiffening of the attachment site when physiological 
forces were applied via mainly v 3, whereas binding and clustering of 5 1 resulted in 
enhanced adhesion strength. The results presented in this aim reinforce the suggestion 
that different matrix ligands, and presumably their interaction with specific integrins, 
allow for differential transduction of matrix stiffness and importantly affect substrate-
mediated alterations in cell phenotype.  
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Figure 5.9:  Schematic of hypothesized stiffness-mediated EMT mechanism.  The 
results of this study indicate that tissue compliance is a synergistic signal that facilitates 
the activation of pro-contractile signals in the cell (i.e. Rho and ROCK) and subsequent 
contraction-mediated TGF  activation.  These effects are context dependent. The 
biochemical composition of the underlying ECM, and hence the integrin specificity of 
cell-ECM interaction, appears to be a master regulator of stiffness-mediated effects on 
epithelial cell phenotype.  This proposed model suggests that therapeutic approaches to 
cancer and fibrosis need to focus equally on modification of the ECM 
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Force application to the focal adhesion complex leads to recruitment and activation of 
signaling proteins like FAK, Src, and Shc whose major downstream targets are Rho 
GTPases.  Importantly, activation of the Rho signaling cascade leads to cytoskeletal 
rearrangement and increased cell contractility.  These cytoskeletal/contractile 
perturbations are now directly linked to activation of TGF  via integrin-mediated release 
of the active growth factor from the Latency Associated Protein. (4, 20, 40)  The 
consequence of this “secondary effect” of tissue stiffness is the transformation of cell 
types – fibroblasts to myofibroblasts, (20) epithelial to mesenchymal transition, etc. 
In conclusion, these studies demonstrate, for the first time, that tissue compliance is a 
critical factor in the determination of EMT and that matrix stiffness acts synergistically 
with integrin-mediated compliance matching in the activation of cell contractility and 
subsequent TGF  activation.  These findings, along with others‟, suggest that therapeutic 
approaches to cancer metastasis and fibrosis that focus on the cell only are critically 
flawed.  The pathological extracellular microenvironment (the ECM and its mechanical 
properties) presents pro-malignant signals that ensure the progression of the disease 
despite any acute eradication of the resident cells.  How one modifies the biochemical 
and biophysical microenvironment may be a greater determinant in the success of future 
therapeutics. 
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EMT is a critical process in the progression of invasive pathologies like cancer 
and fibrosis, therefore, it is essential that this process is fully understood in order to gain 
therapeutic insights.  This dissertation provides evidence that the micromechanical 
environment with which epithelial cells interact is a strong contributor to EMT; however, 
integrin specificity is the ultimate driving force behind EMT.  The results presented here 
suggest that EMT following αv integrin binding on rigid substrates results in increased 
levels of TGFβ activation as a result of increased cell contractility.  These results provide 
many insights into the onset and progression of pathological EMT and have implications 
in development of new treatment for fibrotic diseases. In addition, these results provide 
new design parameters for tissue engineering applications that seek to design cell 
instructive matrices.  
One of the main contributions of this work is that it challenges current notions about the 
role of Fn in the progression of EMT.  Many recent studies have implicated Fn as a key 
contributor to the onset of fibrotic pathologies by increasing cell contractility and TGFβ 
activation; (1-4) however, this work illustrates a different paradigm.  Recent studies by 
Kim et al. showed in vitro that ATII epithelial cells undergo spontaneous EMT in 
response to provisional matrices (fibrin-fibronectin) but not in response to laminin-
collagen matrices through a mechanism involving v 6 integrin mediated activation of 
endogenous TGF , suggesting that the mere presence of fibronectin would trigger a 
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cascade of EMT events in an epithelial tissue.  Epithelial cells in the lung and other 
tissues routinely engage fibronectin matrices during wound repair and yet disease onset 
does not occur in the vast majority of these cases.  This dissertation demonstrates Fn-
mediated EMT is much more complicated than simple engagement of Fn, rather this 
work suggests two important concepts regarding epithelial engagement of Fn and the 
onset and progression of EMT.  1)  The molecular conformation of Fn, for example 
folded vs. unfolded, determines integrin specific binding and subsequent inhibition or 
promotion of EMT.  A more stabilized version of the molecule displaying RGD and 
PHSRN in close proximity engages α3β1 and α5β1 integrins promoting normal epithelial 
phenotypes, while a version of the molecule displaying only the RGD site however, 
cannot support binding of α3β1, but rather will engage αv integrins, become contractile, 
activate TGFβ and undergo EMT.  2)  The mechano-environment in which cells interact 
with Fn is another critical determinant for the onset of EMT.  Cells engaging Fn on soft 
substrates are not able to generate intracellular tension that is necessary to activate latent 
TGFβ and will maintain an epithelial phenotype.  These points taken together suggest it is 
not merely interactions with Fn that lead to EMT, but rather uncontrolled interactions 
with Fn in perpetually unfolded conformations and/or stiff environments that lead to 
pathological EMT.     
Fn-stiffness Mediated EMT 
While this work provides new insights into how the ECM mechanical environment and 
integrin specificity induce or inhibit EMT, it opens the door for numerous additional 
questions.  The work investigating Fn-stiffness mediated EMT defines a cyclic process of 
increased substrate stiffness leading to increased contractility, which in turn leads to 
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increased TGFβ activation, which drives EMT, resulting in more contractile phenotypes 
and further perpetuation of the process; however, the initiating factor of this cyclic 
process remains unclear.  Interestingly, recent studies into the progression of renal 
fibrosis show that the ECM actually becomes stiff prior to the development of fibrosis, 
(5) implicating increased contractility on increasingly stiff surfaces as the initiating factor 
in this cyclic process.  In vitro, this could be demonstrated experimentally by inducing 
contractility with pharmacological agents on soft substrates and observing TGFβ 
activation and EMT.  Furthermore, inducing contractility on soft surfaces and inhibiting 
TGFβ should result in the maintenance of an epithelial phenotype.  Experiments such as 
these would further implicate increased tissue stiffness in the onset and progression of 
EMT, however, it remains unknown what produces the initial stiffening of matrix.  It 
seems most likely that some initial event, be it injury, viral infection, etc., would initiate 
the clotting cascade and inflammatory response, recruiting macrophages and matrix 
producing fibroblasts.  If the inflammatory response was uncontrolled and lead to over 
activation of resident fibroblast populations and excessive ECM production, the result 
would be a decrease in the matrix compliance.    The surrounding epithelial cells would 
sense these changes and potentially undergo EMT, leading to more ECM producing 
fibroblasts and further perpetuate the disease.  Being that fibrosis is a progressive disease, 
this seems a likely mechanism through which the disease compounds.  Studies 
investigating the progression of tissue stiffening in fibrotic diseases in vivo and 
correlating stiffening to the first signs of EMT would help to fully understand the 
dynamics of ECM stiffening and the onset of EMT.  Using an SPC specific promoter, 
Kim et al. elegantly showed that ATII specific EMT does incur in vivo in bleomycin 
 - 136 -   
induced pulmonary fibrosis.  This system could be combined with AFM analysis of living 
lung slices utilized in this dissertation and by others (6) to fully elucidate the dynamics of 
EMT and tissue stiffening.   
Integrin Specific Binding in EMT 
While increased stiffness is clearly a driving factor in Fn-mediated EMT, the results 
presented here suggest that integrin specificity is the primary determinant of EMT vs. 
normal wound healing.  (7)  In addition to characterizing changes in tissue stiffness 
overtime in in vivo fibrotic models, studies characterizing dynamic changes in integrin 
expression and/or binding over time and correlating those to EMT responses in vivo 
could provide insight into these complex ECM/cell dynamics.  In addition, little is known 
about integrin binding on rigid vs. soft substrates, however there is some evidence that 
α5β1 and αvβ3 binding is differential on soft vs. hard substrates.  α5β1 binding has been 
shown to exhibit a “catch” bond type response on stiffer substrates, (8) and αvβ3 in 
complex with receptor-like protein tyrosine phosphatase α (RPTPα) contributes to 
stiffness sensing at the leading edge of fibroblasts.  (9)  However, neither of these studies 
considered the contribution of additional integrins. Because integrin binding seems to be 
the primary driver in the onset of EMT, it is critical to know and understand the 
differences in integrin binding on soft vs. hard substrates.  
Another important concept presented by this work is the role of the Fn synergy 
site in EMT.  While many studies have shown the implications of Fn unfolding and 
increases in the spacing between the RGD and PHSRN sites in directing cell fate (and in 
this study, EMT), it remains unclear to what degree, if at all, Fn unfolding occurs in vivo.  
Tools allowing for detection of Fn unfolding in vivo would provide much needed insight 
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into the role of alterations in the spacing between the RGD and PHSRN sites in 
physiologically relevant systems.  If tools such as these were developed, they could be 
used in conjunction with the ATII cell tracking system described previously to potentially 
correlate increased spacing between the RGD and PHSRN sites and EMT in vivo.  
Interestingly, it has been shown in vitro using FRET techniques, that highly contractile 
fibroblasts associated with pulmonary fibrosis increasingly unfold Fn matrices.  (10)  
EMT would result in an increasing number of contractile cells, which theoretically could 
increasingly unfold Fn in the surrounding ECM, further compounding EMT.  Probes for 
detecting folded vs. unfolded Fn in vivo could provide critical insight into the existence 
of such hypothesized events and could potentially be engineered to target therapeutics to 
fibrotic regions containing chronic levels of unfolded Fn.   
The degree of Fn unfolding in vitro on soft vs. stiff substrates also remains unclear.  It 
has been suggested that Fn becomes unfolded when adsorbed to stiff substrates such as 
seen on tissue culture plastic. (11-13)   It is unknown if the converse is true; does Fn exist 
as a more compact, i.e. less unfolded, molecule on soft substrates?  It has been 
hypothesized that Fn is one of the key molecules in “mechano-sensing”   (14) and, if true, 
could be one mechanism through which cells “sense” their mechanical environment.  The 
studies presented here suggest that Fn-stiffness mediated EMT is the result of increased 
contractility with increasing stiffness, and subsequent increased TGFβ activation; If Fn 
becomes increasingly unfolded with increasing substrate stiffness, increased contractility 
could result from increased αv integrin engagement. 
Once more highlighting the importance of the Fn synergy site in directing cell phenotype, 
this work shows for the first time that Fn binds the epithelial integrin α3β1 in a PHSRN-
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dependent manner and, in the context of SPR studies, stabilized FnIII9‟10 domains bind 
integrin α3β1 with affinities similar those of Ln.  These results provide insight into how 
an epithelial cell might interact with a dynamic ECM in a wound healing environment to 
promote normal wound healing.  As depicted in Figure 6.1, during normal homeostasis, 
an epithelial cell interacts predominantly with Ln through engagement of integrin α3β1.  
(15)  In response to injury, epithelial cells will be exposed to Fn, and assuming Fn exists 
in a more compact form in which PHSRN and RGD are in close proximity, the epithelial 
cell will continue to engage integrin α3β1.  This could potentially facilitate α5β1 binding, 
resulting in normal wound repair and a smooth transition back to a normal Ln matrix 
(Figure 6.1A).  However, if after initial injury cells interact with a more unfolded 
conformation of Fn, as a result of any of the afore mentioned modes of unfolding, in 
which the RGD and PHSRN sites are no longer in close proximity, the epithelial cell will 
no longer be able to engage integrin α3β1 and will rather result in αv integrin binding, 
leading to altered wound healing.  Unregulated αv integrin engagement has been linked 
to a host of pathological conditions associated with fibrotic conditions, including 
increased contractility, increased TGFβ activation, and increased EMT.  (1)  This 
proposed interaction highlights the importance of the ECM microenvironment in 
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Figure 6.1: Proposed role of Fn unfolding on epithelial wound healing events:  The 
studies presented here indicate that the Fn synergy site contributes to integrin α3β1 
binding. The compact form of the molecule, with the RGD and PHSRN sites in close 
proximity, promotes integrin α3β1 binding and inhibits contractile signaling and TGFβ 
activation.  The extended form of the molecule, with the RGD and PHSRN sites at a 
distance to great to be bound by the same integrin, promotes integrin αv binding and 
leads to the activation of pro-contractile signals in the cell (i.e. Rho and ROCK) and 
subsequent contraction-mediated TGF  activation and EMT. This proposed model 
suggests that understanding the dynamics of Fn conformational changes in vitro are 
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Fibrosis Therapeutics 
From a therapeutic point of view, this work provides many insights into designing 
effective therapeutics for fibrotic pathologies.  Because TGFβ is a primary inducer of 
EMT many recent therapeutic strategies have targeted TGFβ or TGFβ activating integrins 
such as αvβ6, for example through monoclonal antibodies or knock-out models. (16-18)  
The studies presented here suggest that cell contractility is a primary contributor to EMT 
through TGFβ activation and that it can occur in response to increased stiffness and the 
underlying ECM.  Therapeutic schemes targeting “relaxing” the underlying ECM could 
prove to be more effective.  This could be achieved through reducing a cell‟s ability to 
respond to a stiff matrix by inhibiting cell contractility, directly decreasing matrix 
stiffness by matrix metalloproteases, or combinatorial methods encompassing both of 
these approaches.  However, inhibiting cell contractility in the lung could prove to be 
highly detrimental to breathing, so approaches such as these would need to be highly 
controlled and specifically targeted to fibrotic regions. These methods could potentially 
prove to be effective methods for inhibiting EMT in that they will get to the root of the 
problem of uncontrolled TGFβ activation.         
Implications in Biomaterial Design and Regenerative Medicine Applications 
The findings of this dissertation also have implications in traditional biomaterial 
design.  Biomaterials often elicit fibrotic responses, which are characterized by excessive 
deposition of extracellular matrix (ECM) and hardening of the surrounding tissue. 
Biomaterial-induced fibrosis, best known as the foreign body capsule, consists of a thick 
collagen capsule surrounding the biomaterial.  (19)  Similarities exist between 
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biomaterials-induced fibrosis and many other fibrotic pathologies, including pulmonary 
fibrosis.  As with many fibrotic pathologies, biomaterials-induced fibrosis is thought to 
result from unresolved inflammation.  Biomaterials-induced-fibrosis can lead to a host of 
problems including loss of material function and loss of function in the surrounding 
tissue due to excessive scar tissue formation.  This work suggests that that EMT could 
result in response to increasingly rigid materials.  In order to design effective 
biomaterials, the effects of material properties, such as elasticity, on cellular responses to 
materials should be considered.  In particular, as evidence of mechanical effects on 
biology continue to mount, it is clear that biomaterial scientists must strive harder to 
mimic the physiological environment of cells, from growth factor concentrations and 
ECM molecules displayed to micromechanical properties. 
These results also open many possibilities in the field of tissue engineering and 
regenerative medicine.  Directing specific cell behaviors, particularly differentiation, in 
response to biomaterials for regenerative medicine applications is thus far a mostly 
unrealized goal.  (20, 21)  Many current technologies have been inspired by the 
reductionist point of view and have focused on developing simple and merely adequate 
environments that facilitate simple cell processes, such as cellular adhesion.  For 
example, many groups have used the RGD motif to serve as an „ECM mimetic‟ in the 
context of synthetic biomaterials.  (22)  However, even if ECM-derived peptides have 
largely demonstrated their utility through supporting cell adhesion, the lack of biological 
specificity of many of these peptide motifs is simply not optimal for controlling more 
integrated processes, such as differentiation.  (23)  Inducing complex cellular processes, 
which is the goal of many tissue engineering endeavors, requires more specific integrin-
 - 142 -   
signaling scaffolds.  However, the use of full length ECM molecules is also not ideal due 
to the inherent capacity of ECM to bind multiple and diverse integrins and growth 
factors.  For that reason, many groups have begun to incorporate engineered ECM 
variants that display only a fraction of the native ECM protein complexity yet still 
attempt to provide sufficient instruction for directing cell phenotype.  (23-25)  The 
FnIII9‟10 fragments created here can provide new tools for designing these integrin-
specific microenvironments for directing epithelial cell fate.  Similar fragments have been 
used recently to induce stem cell differentiation in 3D gels and promote osseointegration 
in vivo.  (23, 25)  Though this work has mainly focused on the role of EMT in 
pathological conditions, induction of EMT may be favorable for some tissue engineering 
applications aiming to create complex cellular tissues which require epithelial and 
mesenchymal cells in close proximity.  To design such a complex tissue, one could 
imagine patterning epithelial promoting fragments, such as FnIII9‟10, and mesenchymal 
promoting fragments, such as FnIII10, in defined spatial orientations and patterns.  
Furthermore, fragments could be incorporated into more complex systems, featuring 
varying levels of elasticity, to induce epithelial or mesenchymal phenotypes.  Utilizing 
integrin-specific fragments in conjunction with well defined elastic moduli creates many 
new design opportunities for tissue engineering applications.    
In conclusion, this dissertation shows for the first time that alveolar epithelial cell 
EMT is influenced by both integrin-specific engagements to the central cell binding 
domain of Fn as well as substrate stiffness. These EMT events are likely due to an 
increase in cell contractility, ultimately resulting in increasing TGF  activation.  
Furthermore, these studies show that Fn can engage α3β1 with high affinity through 
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 type III domains when the RGD and PHSRN sites are in 
close proximity.  This work highlights that EMT is a complicated process, likely resulting 
from a shift in both the protein composition and the mechanical microenvironment of the 
surrounding ECM.  Furthermore, this work highlights that epithelial cell interactions with 
Fn are complex and if not tightly controlled can lead to pathological progression of 
fibrotic conditions.  These findings open new paths for potential treatments of fibrotic 
diseases, offer new tools for designing cell instructive matrices, and provide insight into 
designing effective biomaterials.  Further investigation into the role of Fn-mediated EMT 
could provide many new avenues for discovery in the field of mechanotransduction.  
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FIBRONECTIN-INDUCED STIFFNESS-MEDIATED EMT:  
ANALYSIS IN L2 CELLS 
 
Initial studies investigating the role of substrate stiffness in Fn-induced EMT were 
performed using L2 cells, an ATII-like cell line.  Initial characterization of PA-gels 
utilized for analysis are presented here, along with analysis of proliferation, mRNA 
expression of epithelial and mesenchymal markers, and cell spreading in response to 
increases in substrate stiffness.  The results presented here indicate that Fn-induced 
stiffness-mediated EMT is not specific to RLE-6TN cells, but rather, can occur in 
multiple epithelial cell lines.    
 
 
Materials and Methods 
 
Poly-acrylamide gel production 
 
To determine the role of substrate stiffness on EMT events, poly-acrylamide (PA) gels of 
varying bis concentrations were created.  PA gel solutions were produced by combining 
acrylamide and bis to final concentrations of 10% acrylamide (Biorad, Hercules, CA, 
USA) and 0.3%, 0.07%, 0.13%, or 0.26% bis (Biorad) and then polymerized under 
nitrogen by the addition of ammonium persulfate (VWR, West Chester, PA, USA) and 
N,N,N‟,N‟-tetramethylethylenediamine (Biorad, Hercules, CA, USA) (0.05% final 
concentration each).  The gels were allowed to polymerize under nitrogen for 
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approximately 15 minutes. Because PA is anti-adhesive, human plasma fibronectin (Fn) 
(BD Bioscience, San Jose, California, USA) was attached to the surface using the 
heterobifunctional crosslinker sulfosuccinimidyl-6-(4‟-azido-2‟ nitrophenyl-
amino)hexanoate (sulfo-SANPAH; Pierce Chemical Co., Rockford, IL., USA). 
PA gel elasticity determination 
The relationship between Young‟s modulus of the gel and bis concentration was 
determined macroscopically as previously described by Pelham et al.  Briefly, 3 x 2 x1 
mm gels of varying bis concentrations were produced and a weight was attached to the 
end.  The change in length upon attachment of the weight was measured and E 
determined by the following equation:  
E= /  
E as a function of bis concentration was determined through linear regression.  3 
independent experiments were performed.   
Cell culture 
L2 cells, an alveolar epithelial cell line (a generous gift from Prof. Douglas Eaton, Emory 
University, Atlanta, GA), were maintained in Coons modified media supplemented with 
10% FBS, 1% P/S.  To determine the affect of substrate stiffness on L2 cell fate, cells 
were plated on PA gels with Fn cross-linked on the surface with the following rigidities:  
E=8.5 kPA, 13.3 kPA, 20.5 kPA, 36.1 kPA, or on tissue culture plastic (TCP) coated with 
Fn or Ln as a control.  Cells were plated at a density of 25,000 cells/cm
2
 in Coon‟s 
modified media supplemented with 10% FBS, and 1% Penicillin/ Streptomycin in the 
absence or presence of 10 μM Y-27632 (EMD Biosciences, Gibbstown, NJ, USA).  
Media was changed every 48 hours. 
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BrdU proliferation assay 
Proliferation in response to substrate stiffness was determined with a standard 
Bromodeoxyuridine (BrdU) proliferation assay (Exalpha Biologicals, Shirley, MA, 
USA).  L2 cells were plated on substrates of varying stiffness and cultured for 24, then 
BrdU was added to the media and incubated for 24 hours.  Cells were then fixed with 
glutaraldehyde and an ELISA performed for BrdU according to manufacturer‟s 
specifications.  Three independent triplicate experiments were performed.  Data shown is 
pooled for all experiments performed. Proliferation was normalized to the lowest and 
highest levels of proliferation, such that cells cultured on the lowest stiffness substrate, 
E=8.5 kPA, was equivalent to 0%, and cells cultured on E=26.5 was equivalent to 100% 
proliferation. 
Analysis of gene expression 
L2 cells were cultured on substrates of varying stiffness for 1 week in the absence or 
presence of 10 µM Y-27632.  Cells were trypsinized, mRNA isolated (RNAeasy, Qiagen, 
Valencia, CA, USA) and c-DNA generated (High Capacity cDNA Reverse Transcription 
Kit, Applied Biosystems, Foster City, CA, USA).  Primers (Invitrogen, Carlsbad, CA, 
USA) used for q-PCR reactions were as follows:  N-cadherin forward 
AGGGCCTTAAAGCTGCTGACA; N-cadherin reverse 
TCATAGTCGAAGACTAAAAGGGAGTCATAT; Vimentin forward 
CCCAGATTCAGGAACAGCAT; Vimentin reverse CACCTGTCTCCGGTATTCGT 
(designed using Primer3Plus software); E-cadherin forward 
TGAGCATGCCCCAGTATCG ; E-cadherin reverse CTGCCTTCAGGTTTTCATCGA; 
-actin forward ACCCGCCACCAGTTCGCCAT; -actin reverse 
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CTTGCTCTGGGCCTCGTCGC; surfactant protein C (SPC) forward 
GTGGTTGTGGTGGTAGTC; SPC reverse AATAGAGAAGGTAGCGATGG: 
Plasminogen activator inhibitor-1 (Pai-1) forward CACAGTGCTGGGTGTAATGG; Pai-
1 reverse GTTTGTGGGGCAGCTATTGT (designed using Primer3Plus software). Q-
PCR was performed on a Step One Plus ABI thermocycler (Applied Biosystems) using 
Power SYBR Green Master Mix (Applied Biosystems).  Data was analyzed using the 
∆∆CT method using -actin as the endogenous control and comparing expression levels 
to cells cultured on the lowest stiffness substrate (E=8.6 kPA).  Q-PCR reactions were 
run in triplicate and performed for 3 independent experiments.  Data shown was pooled 
from 3 independent experiments. 
Analysis of cell shape and cytoskeleton organization 
L2 cell contractility in response to substrate stiffness was determined through analysis of 
stress fiber formation by culturing cells on Fn-substrates of varying stiffness and Fn or 
Ln-coated glass slides in the absence or presence of 10 µM Y-27632 for 1 week.  Media 
was changed every 48 hours.  Cells were then fixed with 4% formaldehyde, actin was 
stained with Texas-red phalloidin (Invitrogen) and nuclei were stained with Hoescht stain 
(Invitrogen).  Coverslips were mounted and images acquired with a Nikon Eclipse (TiE) 
inverted fluorescence microscope at 20X magnification (PlanApo 100X, 1.4 NA oil-
immersion objective) with a CoolSNAP HQ2 Monochromatic CCD camera.  
Representative images are presented. 
Analysis of circularity  
Cells were cultured on substrates of varying stiffness for 1 week in the absence or 
presence of 10 µM Y-27632 and the cytoskeleton visualized as described above. Area 
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and perimeter of individual cells was determined for each condition using Image J (NIH 
Freeware) image processing software, then circularity was determined using the equation 
circularity = 4π(area/perimeter
2
).   Three independent images were analyzed for each 
condition, and at least 10 cells were analyzed per image.  Data is pooled from all 3 
images analyzed per condition. 
Statistical Analysis 
All statistical analysis was performed by multi-variate ANOVA using Prism (Graphpad 
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Results 
Young‟s Modulus directly correlates with percent bis concentration 
 
To determine the relationship between percent bis concentration of the PA gels and 
Young‟s modulus (E), 3 x 2 x1 mm gels of varying bis concentrations were produced and 
a weight was attached to the end.  The change in length upon attachment of the weight 
was measured and E determined by Hooke‟s law using the following equation:  
E= /  
where σ=force/area and ε=Δl/l.  E as a function of bis concentration was determined 
through linear regression.  It was found that E increases linearly with percent bis 
concentration (%bc), and this relationship can characterized by the following equation: 
E = 120.12(%bc) + 4.9 
Using regression analysis, this relationship was found to have an R
2
 value of 0.986 
(Figure A.1A).  To determine if the amount of Fn cross-linked to the surface of the gels 
was equivalent for PA gels of varying rigidities, gels were produced with 0.03%, 0.07%, 
0.13%, and 0.26% bis concentrations and then Fn was cross-linked to the surface of the 
gels using sulfo-SANPAH.  Relative concentrations of Fn on the surface of the PA gels 
was determined using a modified ELISA approach.  A One-way ANOVA showed there 
was no statistically significant difference in the amount of Fn cross-linked to the surface  
between the 4 rigidities (Figure A.1B). 
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Figure A.1: Young’s modulus directly correlates with percent bis concentration.  
Young‟s modulus was determined as a function of bis concentration by creating PA gels 
of varying percent bis concentration and measuring  and  (A).  Alexa Flour 488 
conjugated Fn was cross-linked to gels of varying percent bis concentration and then 
relative amounts of Fn on the surface of the gels was determined by measuring 
fluorescence with excitation and emission at 495 and 519 nm respectively (B).      
 
 
Cells display increasing levels of proliferation with increasing stiffness 
 
To investigate if substrate stiffness modulates L2 cellular behavior, L2 proliferation was 
analyzed.  L2 cells were cultured on Fn-substrates of varying stiffness or Ln coated TCP 
for 24 hours in the absence or presence of 10 M Y-27632, at which point proliferation 
was analyzed by BrdU incorporation (Figure A.2). A standard ELISA was performed for 
BrdU and absorbance measured at 450 nm, and proliferation was normalized to the 
lowest and highest levels of proliferation, such that cells cultured on the lowest stiffness 
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substrate, E=8.5 kPA, was equivalent to 0%, and cells cultured on E=26.5 was equivalent 
to 100% proliferation.  L2 cells cultured on the lowest stiffness substrate, E=8.5 kPa, 
displayed minimal proliferation (0% +/- 20.42).  To confirm that the lack of proliferation 
observed was not due to cell death, a live:dead assay was performed, and it was found 
that cells displayed a high percentage of viable cells on all substrates analyzed (data not 
shown).  Proliferation was found to display a biphasic response, with proliferation 
increasing with increasing stiffness on gels of E=13.3 kPA and E=20.5 kPA (71.53% +/- 
27.89 and 100 +/- 21.25 respectively) then decreasing slightly on the highest stiffness gel, 
E= 36.1 kPA, (60.05% +/- 10.97) and on TCP (29.58% +/- 1.778). One-way ANOVA 
analysis showed significant difference in proliferation on the lowest stiffness gels, E=8.5 
kPa, and gels with E=20.5 kPa, p<0.01.  In addition, proliferation on gels with E=20.5 
kPA was significantly higher than proliferation on TCP, p<0.05.  Differences in 
proliferation were abrogated through the addition of 10 M Y-27632, and no statistical 
differences in proliferation were observed in the presence of the ROCK inhibitor 
(p=0.86).   
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Figure A.2:  Proliferation of L2 cells cultured on substrates of varying stiffness after 
24 hours.  Cells were cultured for 24 hours on PA gels of varying stiffnesss, Fn, or Ln-
coated TCP in the absence (A) or presence (B) of 10 μM Y-27632 ROCK inhibitor, then 
proliferation was measured with a BRDU assay.  Data is pooled from three independent 
triplicate experiments and is expressed as percent proliferation; E=8.5 kPA, 0% and 





Cells increase expression of mesenchymal markers when cultured on gels of increasing 
stiffness and this is inhibited by the addition of ROCK inhibitor 
To determine if observed differences in morphology of L2 cells cultured on substrates of 
varying stiffness resulted in differences in gene expression, expression of epithelial (SPC, 
alveolar specific and E-cadherin) and mesenchymal (vimentin, N-cadherin) genes by q-
PCR were analyzed.  mRNA was isolated from cells cultured for 1 week on gels with E= 
8.5 kPA, 13.3 kPA, 20.5 kPA, 36.1 kPA, or Fn or Ln-coated TCP in the absence (green 
bars) or presence (red bars) of 10 μM Y-27632  (Figure A.3).  qPCR data was analyzed 
 - 155 -   
using the ΔΔCt method, using β-actin as the control gene and comparing all samples to 
cells cultured on the lowest stiffness substrate (E=8.5 kPA).  In general, cells increased 
expression of vimentin and N-cadherin as substrate stiffness increased, which coincided 
with a concomitant decrease in expression of SPC and E-cadherin.  Upon addition of Y-
27632 to the culture media, these differences were abrogated.  A one-way ANOVA 
showed no significant differences in expression of any genes analyzed between cells 
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Figure A.3:  q-PCR analysis of gene expression of L2 cells cultured on substrates of 
varying stiffness in the absence or presence of Y-27632.  L2 cells were cultured on 
substrates of varying stiffness or Fn or Ln-coated TCP for 1 week.  RNA was isolated 
and q-PCR performed for various epithelial and mesenchymal markers.  Cells cultured in 
the absence of Y-27632 are presented as green bars, and cells cultured in the presence of 
10 μM Y-2632 are presented as red bars.  Data was analysed using the CT method 
taking reaction efficiency into consideration, using β-actin as the control gene and 








 - 157 -   
 
Cells display different degrees of cytoskeleton alignment on gels of varying stiffness, and 
these differences are negated by the addition of ROCK inhibitor 
Next, cytoskeletal organization and stress fiber formation were analyzed by culturing L2 
cells on substrates of varying stiffness in the absence (Figure A.4A, C, E, G, I) or 
presence (Figure A.4B, D, F, H, J) of 10 μM Y-27632.  Cells were also cultured on Ln 
in the absence or presence of Y-27632 (Figure A.4K, L) due to Ln known role in 
preventing EMT.  After 1 week in culture, cells were stained with Texas-red phallodin to 
visualize the actin cytoskeleton.  In the absence of Y-27632, cells cultured on the lowest 
stiffness substrate (E=8.5 kPA, Figure A.4A) displayed a round morphology and diffuse 
staining for actin.  Cells cultured on the next highest stiffness substrate (E=13.3 kPA, 
Figure A.4C) displayed a slightly more elongated morphology, but continued to display 
on diffuse staining for actin. On the higher stiffness substrates (E=20.5 kPA, 36.1 kPA, 
and TCP Figure A.4E, G, I respectively) cells became more elongated and increasingly 
displayed aligned, thick actin filaments characteristic of stress fibers, and as expected, 
cells cultured on Ln surfaces maintained an epithelial phenotype.  Cells cultured in the 
presence of Y-27632 displayed a round morphology and diffuse staining for actin 
regardless of the stiffness of the underlying substrate.  Cell circularity was calculated to 
quantify differences observed in cell shape (Figure A.4M); values closer to 1 indicated a 
more rounded cell.  Cells exhibited statically significant decreasing circularity values 
with increasing stiffness (p<0.001 each group compared to E=8.5 kPA) with cells 
exhibiting the following circularity values:  E=8.5 kPA, 0.48; E=13.3 kPA, 0.35; E=20.5 
kPA, 0.29; E=36.1 kPA, 0.28; Fn-TCP, 0.33.    The addition of 10 M Y-27632 resulted 
in circularity values greater than 0.42. The addition of Y-27632 to cells cultured on 
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E=20.5 kPA, E=36.1 kPA, and Fn-TCP significantly decreased the increased their 
circularity values compared to the respective stiffness in the absence of Y-27632 inhibitor 
(p<0.001).  Cells cultured on Ln-TCP exhibited similar circularity values in both the 
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Figure A.4: Actin cytoskeleton alignment, stress fiber formation, and changes in cell 
circularity in response to substrate stiffness.  L2 cells were cultured for 1 week on Fn 
substrates of increasing stiffness in the absence (A, C, E, G, I) of presence (B, D, F, H, 
J) of 10 M Y-27632. Cells were also cultured on Ln in the absence or presence of Y-
27632 (Figure K, L).  To analyze stress fiber formation, the actin cytoskeleton was 
visualized by staining with Texas-red phalloidin and the nuclei stained with Hoescht. 
Images are of representative of at least 3 independent experiments.  Cell circularity was 
calculated to quantify differences observed in cell shape (M); values closer to 1 indicate a 
more rounded cell. Fluorescent images were acquired with a Nikon Eclipse (TiE) 
inverted fluorescence microscope at 20X magnification. Three independent images were 
analyzed for each condition and 10 cells were analyzed per image.  Data is pooled from 
all 3 images analyzed per condition.  *** denotes p<0.001. 
 




Epithelial cells exhibit differences in pai-1 expression when cultured on substrates of 
increasing stiffness.  
To determine if differences in substrate stiffness induced changes in Pai-1, a TGF -
specific responsive gene, L2 cells were cultured on substrates of varying stiffness or Fn 
or Ln-coated TCP for 1 week in the absence or presence of 10 M Y-27632 ROCK 
inhibitor and then expression of the Pai-1 gene was determined by q-PCR (Figure A.5).  
In general, cells increased Pai-1 expression as substrate stiffness increased, with cells 
cultured on TCP expressing significantly more Pai-1 than cells cultured on substrates of 
stiffness E=8.5 kPa, 20.5 kPA, and 36.1 kPA (p<0.05).  The addition of 10 M Y-27632 
abrogated this trend, and no statistical significance was seen between groups cultured in 
the presence of the inhibitor. 
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Figure A.5: Pai-1 gene expression analysis.  L2 cells were cultured for 1 week on 
substrates of varying stiffnesss or on Fn or Ln-coated TCP in the absence or presence of 
10 M Y-27632. Levels of expression of the TGF  responsive gene Pai-1 were 
determined by q-PCR.  Fold changes in gene expression were determined by CT 
analysis using GAPDH as the endogenous control and comparing expression to cells 
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